0001365388 FY false High Sierra Technologies, Inc. 0001365388 2020-12-31 iso4217:USD 0001365388 2021-12-31 iso4217:USD i:shares i:shares 0001365388 2019-12-31 0001365388 us-gaap:PreferredStockMember 2019-12-31 0001365388 us-gaap:CommonStockMember 2019-12-31 0001365388 us-gaap:RetainedEarningsMember 2019-12-31 0001365388 us-gaap:PreferredStockMember 2020-12-31 0001365388 us-gaap:CommonStockMember 2020-12-31 0001365388 us-gaap:RetainedEarningsMember 2020-12-31 0001365388 us-gaap:PreferredStockMember 2021-12-31 0001365388 us-gaap:CommonStockMember 2021-12-31 0001365388 us-gaap:RetainedEarningsMember 2021-12-31 0001365388 2020-01-01 2020-12-31 0001365388 2021-01-01 2021-12-31 0001365388 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0001365388 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001365388 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001365388 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001365388 us-gaap:SubsequentEventMember us-gaap:PrivatePlacementMember 2022-02-01 2022-02-10 0001365388 us-gaap:ConvertibleNotesPayableMember 2021-12-31 0001365388 us-gaap:ConvertibleNotesPayableMember 2020-12-31 0001365388 htsi:NotesPayableMember 2021-12-31 0001365388 htsi:NotesPayableMember 2020-12-31 0001365388 htsi:SecuredConvertibleNotesMember 2021-01-01 2021-12-31 i:pure 0001365388 htsi:NotesPayableMember srt:MaximumMember 2021-12-31 0001365388 htsi:NotesPayableMember srt:MinimumMember 2021-12-31 0001365388 htsi:NotesPayableMember 2021-12-31 0001365388 srt:PresidentMember 2021-01-01 2021-12-31 0001365388 srt:MaximumMember 2021-01-01 2021-12-31 0001365388 srt:MinimumMember 2021-01-01 2021-12-31 0001365388 us-gaap:SubsequentEventMember htsi:SecuredNotePrivatePlacementMember 2022-02-11 2022-02-16 0001365388 2021-06-30 0001365388 2022-03-21 utr:sqft

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

~~[X]~~☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE

ACT OF 1934

For the fiscal year ended: December 31, ~~2020~~2021

[☐ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE

ACT OF 1934

For the transition period from to

Commission File Number: 000-52036

HIGH SIERRA TECHNOLOGIES, INC.

(Exact Name of registrant as specified in its Charter)

Colorado

84-1344320

(State or other Jurisdiction of

Incorporation or organization)

(I.R.S. Employer Identification No.)

1495 Ridgeview Drive, Suite 230A

Reno, NV 89519

(Address of Principal Executive Offices)

(775) 410-4100

(Registrant’s Telephone Number, including area code)

Securities registered pursuant to Section 12(b) of the Act: None

Securities registered pursuant to Section 12(g) of the Act: Common Stock, no par value

Indicate by check mark if the Registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ~~[ ]~~☐ No ~~[X]~~☒

Indicate by check mark if the Registrant is not required to file reports pursuant to Section 13 or 15(d) of the Exchange Act. Yes ~~[ ]~~ ☐ No ~~[X]~~☒

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ~~[X]~~☒ No ~~[ ]~~ ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ~~[X]~~☒ No ~~[ ]~~ ☐

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer [☐ ] Accelerated filer [☐ ] Non-accelerated filer ~~[X]~~☒ Smaller reporting company ~~[X]~~☒ Emerging Growth company ~~[X]~~☒

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ~~[ ]~~☐

Indicate by check mark whether the registrant has ~~ﬁled~~filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over ~~ﬁnancial~~financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting ~~ﬁrm~~firm that prepared or issued its audit report. ~~[ ]~~ ☐

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ~~[ ]~~☐ No ~~[X]~~☒

Aggregate Market Value of Non-Voting Common Stock Held by Non-Affiliates

The market value of the voting and non-voting common stock held by non-affiliates at such date (June 30, ~~2020~~2021) was $1430,~~672~~612,~~666~~088.3450, based on 8,~~289~~746,~~642~~311 shares then held by non-affiliates, and a closing bid price of $13.7750 per share on June 30, ~~2020~~2021. All of the Company’s outstanding shares are voting shares.

Outstanding Shares

As of ~~April~~March 1421, ~~2021~~2022 the Registrant had 20,~~326~~494,~~309~~645 shares of common stock outstanding.

Documents Incorporated by Reference

See Part IV, Item 15.

EXPLANATORY NOTES

Except as otherwise indicated by context, references to the “Company,” “we,” “our,” “us,” “Gulf & Orient” and words of similar import refer to “High Sierra Technologies, Inc.,” a Colorado corporation (formerly known as Gulf & Orient Steamship Company, Ltd.), which is the Registrant, and its wholly-owned subsidiaries, High Sierra Technologies, Inc., a Nevada corporation, and Gulf Acquisition, Inc., a Nevada corporation (“Gulf Acquisition”), which was formed as an acquisition subsidiary.

CAUTIONARY STATEMENTS

There has been no established trading market in our common stock for many years. Additionally, many of the approximately 8,289,642 shares issued to non-affiliates in the acquisition of our wholly-owned subsidiary became saleable under Rule 144 in January 2020, and may now be sold into any trading market that may develop for our shares. These factors may result in uncertainty and volatility in the trading price of our common stock that may not have any relation to our current or future prospects.

FORWARD-LOOKING STATEMENTS

This Annual Report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “ongoing,” “plan,” “potential,” “predict,” “project,” “should,” “will,” “would,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time the statements are made and involve known and unknown risks, uncertainties and other factors that may cause our results, levels of activity, performance or achievements to be materially different from the information expressed or implied by the forward-looking statements in this report. These factors include, among others:

2•

our ability to raise capital;

·•

our ability to identify suitable acquisition targets;

·•

our ability to successfully execute acquisitions on favorable terms;

·•

declines in general economic conditions in the markets where we may compete;

·•

unknown environmental liabilities associated with any companies we may acquire; and

·•

significant competition in the markets where we may operate.

You should read any other cautionary statements made in this Annual Report as being applicable to all related forward-looking statements wherever they appear in this Annual Report. We cannot assure you that the forward-looking statements in this Annual Report will prove to be accurate and therefore prospective investors are encouraged not to place undue reliance on forward-looking statements. You should read this Annual Report completely. Other than as required by law, we undertake no obligation to update or revise these forward-looking statements, even though our situation may change in the future.

JUMPSTART OUR BUSINESS STARTUPS ACT DISCLOSURE

We qualify as an “emerging growth company,” as defined in Section 2(a)(19) of the Securities Act of 1933, as amended (the “Securities Act”), as amended by the Jumpstart Our Business Startups Act (the “JOBS Act”). An issuer qualifies as an “emerging growth company” if it has total annual gross revenues of less than $1.0 billion during its most recently completed fiscal year, and will continue to be deemed an emerging growth company until the earliest of:

• ~~the last day of the fiscal year of the issuer during which it had total annual gross revenues of $1.0 billion or more;~~

• the last day of the fiscal year of the issuer ~~following~~during ~~the~~which ~~fifth~~it ~~anniversary~~had oftotal ~~the~~annual ~~date~~gross ofrevenues ~~the first sale~~ of ~~common~~$1.0 ~~equity~~billion ~~securities~~or ~~of the issuer pursuant to an effective registration statement~~more;

• ~~the date on which the issuer has, during the previous three-year period, issued more than $1.0 billion in non-convertible debt; or~~

•the last day of the ~~date~~fiscal onyear ~~which~~of the issuer isfollowing ~~deemed~~the tofifth beanniversary aof ~~“large~~the ~~accelerated~~date ~~filer,”~~of asthe ~~defined~~first insale ~~Section~~of ~~240.12b-2~~common equity securities of the ~~Securities~~issuer ~~Exchange~~pursuant ~~Act~~to ofan ~~1934~~effective ~~(the~~registration ~~“Exchange~~statement; ~~Act”).~~

•

the date on which the issuer has, during the previous three-year period, issued more than $1.0 billion in non-convertible debt; or

•

the date on which the issuer is deemed to be a “large accelerated filer,” as defined in Section 240.12b-2 of the Securities Exchange Act of 1934 (the “Exchange Act”).

As an emerging growth company, we are exempt from various reporting requirements. Specifically, we are exempt from the following provisions:

• ~~Section 404(b) of the Sarbanes-Oxley Act of 2002, which requires evaluations and reporting related to an issuer’s internal controls;~~

• Section ~~14A~~404(ab) of the ~~Exchange~~Sarbanes-Oxley Act of 2002, which requires anevaluations ~~issuer~~and toreporting ~~seek~~related ~~shareholder~~to ~~approval~~an ofissuer’s ~~the~~internal ~~compensation of its executives not less frequently than once every three years~~controls; ~~and~~

• Section 14A(b) of the Exchange Act, which requires an issuer to seek shareholder approval of its so-called “golden parachute” compensation, or compensation upon termination of an employee’s employment.

Section 14A(a) of the Exchange Act, which requires an issuer to seek shareholder approval of the compensation of its executives not less frequently than once every three years; and

•

Section 14A(b) of the Exchange Act, which requires an issuer to seek shareholder approval of its so-called “golden parachute” compensation, or compensation upon termination of an employee’s employment.

Under the JOBS Act, emerging growth companies may delay adopting new or revised accounting standards that have different effective dates for public and private companies until such time as those standards apply to private companies. We have elected to use the extended transition period for complying with these new or revised accounting standards. Since we will not be required to comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for other public companies, our financial statements may not be comparable to the financial statements of companies that comply with public company effective dates. If we were to elect to comply with these public company effective dates, such election would be irrevocable pursuant to Section 107 of the JOBS Act.

PART I

ITEM 1. BUSINESS

Business Development

We were incorporated in the State of Colorado on May 9, 1996, with an authorized capital of 55,000,000 shares, comprised of 50,000,000 shares of common stock, and 5,000,000 shares of non-voting preferred stock, both with no par value per share. We were formed for the primary purpose of engaging in the business of marine transportation and to provide ocean going shipping of goods internationally. Our proposed business operations were unsuccessful, and we had no material business operations from March 7, 1997 through December 31, 2018.

In May of 1996, we issued “restricted securities” (common stock) at our inception, and conducted an offering under Rule 504 of Regulation D of the Securities and Exchange Commission (the “SEC”). This offering was also conducted in accordance with Section 11-51-308(1)(p) of the Colorado Revised Statutes that allowed “public solicitation” of “accredited investors.” Our proposed business operations were unsuccessful, and we had no material business operations from March 7, 1997 through December 31, 2018.

Copies of our Articles of Incorporation and our By-Laws were attached to our Form 10-SB Registration Statement that was filed with the SEC on June 7, 2006, and were attached to our Form 10-K Annual Report for the period ended December 31, 2013. See Part IV, Item 15.

We voluntarily filed our Form 10-SB Registration Statement so that we could become a “reporting issuer” under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

On December 31, 2018 (the “Closing Date” or “Closing”), we entered into a Share Exchange Agreement (the “Agreement”) with High Sierra Technologies, Inc., a Nevada corporation (“High Sierra”) and all of the shareholders of High Sierra, pursuant to which we acquired 100% of the issued and outstanding shares of common stock of High Sierra (the “Share Exchange” or “Acquisition”). The Acquisition of High Sierra was consummated on the same date, and High Sierra is now a wholly-owned subsidiary of the Company. The names of the shareholders of High Sierra are listed in the Agreement, a copy of which is attached to our Form 8-K Current Report filed with the SEC on January 2, 2019 as Exhibit 2.1. As consideration for the Share Exchange, we issued a total of 15,433,025 shares of our common stock to the High Sierra shareholders.

The Share Exchange was treated as a recapitalization of the Company for financial accounting purposes. High Sierra is considered the acquirer for accounting purposes, and our historical financial statements before the Share Exchange ~~will~~were be replaced with the historical financial statements of High Sierra.

~~The~~Under ~~issuance~~the ofterms ~~shares~~ of the ~~Company’s~~Agreement, ~~common~~as ~~stock~~consideration for tothe ~~holders~~Acquisition, the shareholders of High Sierra’s ~~capital~~who ~~stock~~collectively inowned ~~connection~~15,433,025 ~~with~~shares ~~the~~of ~~Share~~common ~~Exchange~~stock ~~was~~of ~~not~~High ~~registered under the Securities Act~~Sierra, inreceived one ~~reliance~~(1) ~~upon~~share ~~the~~of ~~exemption~~our ~~from~~common ~~registration~~stock ~~provided~~for byeach ~~Section~~one 4(21) share of ~~the~~High ~~Securities~~Sierra ~~Act,~~common ~~which~~stock ~~exempts~~exchanged ~~transactions~~in bythe antransaction. ~~issuer~~As ~~not~~a ~~involving~~result, ~~any~~the ~~public~~High Sierra ~~offering~~shareholders, ~~and~~as ~~Regulation~~a Dgroup, ~~and/or~~received ~~Regulation~~15,433,025 Sshares ~~promulgated~~of byour ~~the~~common ~~SEC~~stock ~~under~~in ~~that~~the ~~section.~~exchange, ~~These~~which ~~securities~~represented ~~may~~approximately ~~not~~76.44% of bethe ~~offered~~20,189,642 orissued ~~sold~~and inoutstanding ~~the~~shares ~~United~~of ~~States~~our ~~absent~~common ~~registration~~stock orimmediately anfollowing ~~applicable exemption from~~ the ~~registration requirement~~Acquisition.

In connection with the Acquisition of High Sierra, we also issued 1,087,525 shares of our common stock to Michael Vardakis, the former President and director of the Company, for a cash payment of $21,750.50, 120,000 shares of our common stock to Melissa Ladakis, the former Secretary and director of the Company, for services rendered which were valued at $0.02 per share, 30,000 shares of our common stock to Lynette Kelch, for services rendered which were valued at $0.02 per share; and 1,800,000 shares of our common stock to Biored, N.V., a Belgian corporation (“Biored”). Biored loaned the Company $500,000 in early June 2018 at five percent (5.0%) interest per annum. Biored converted the principal amount of its loan ($500,000) and accrued interest of approximately $14,500 to the 1,800,000 shares of our common stock which it received, at a conversion price of approximately $0.2858 per share.

Similarly, the issuance of our shares of common stock to Biored, Mr. Vardakis, Ms. Ladakis and Ms. Kelch was not registered under the Securities Act, in reliance upon the exemption from registration provided by Section 4(2) of the Securities Act, which exempts transactions by an issuer not involving any public offering, and Regulation D and/or Regulation S promulgated by the SEC under that section. These securities may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirement.

Under the terms of the Agreement, as consideration for the Acquisition, the shareholders of High Sierra who collectively owned 15,433,025 shares of common stock of High Sierra, received one (1) share of our common stock for each one (1) share of High Sierra common stock exchanged in the transaction. As a result, the High Sierra shareholders, as a group, received 15,433,025 shares of our common stock in the exchange, which represented

approximately 76.44% of the 20,189,642 issued and outstanding shares of our common stock immediately following the Acquisition.

The Agreement provided that at the Closing the Company would cause its Board of Directors to elect Vincent C. Lombardi to the Company’s Board of Directors to serve together with Michael Vardakis, that the pre-Closing officers of the Company (Michael Vardakis and Melissa Ladakis) would resign, and that the Board of Directors would appoint Vincent C. Lombardi as Chief Executive Officer and President, and Gregg W. Koechlein as the Chief Financial Officer, Secretary and Treasurer of the Company. Mr. Koechlein was also appointed as the Chief Operating Officer. This all occurred on the Closing Date.

On March 25, 2019 a Special Meeting of the Company’s Stockholders was held at which the stockholders voted to change the Company’s name to High Sierra Technologies, Inc., and to approve certain other changes in the Company’s Articles of Incorporation which are described in the Company’s Definitive Proxy Statement. These changes became effective on April 1, 2019. A copy of our Amended and Restated Articles of Incorporation is attached to the Company’s Annual Report for the year ended December 31, 2018 as Exhibit 3.2.5

On March 25, 2019 following the shareholder meeting, Michael Vardakis resigned as a director of the Company. On March 26, 2019, Vincent C. Lombardi, as the only remaining director of the Company, appointed Gregg W. Koechlein as a director of the Company to fill the vacancy left by Mr. Vardakis’ resignation.

Description of Business

The Company’s business is now focused on the business of its wholly-owned subsidiary, High Sierra Technologies, Inc. (“High Sierra”). High Sierra was incorporated in the State of Nevada in August of 2018. It was formed with the intention that it would become the assignee, owner and licensor of certain Intellectual Property that was, prior to assignment, the property of Vincent C. Lombardi, Ph.D. (the “Intellectual Property”) who is an officer, director and co-founder of High Sierra. High Sierra was further formed with the goal that it would continue to develop and expand its intellectual property portfolio with an emphasis on the recreational cannabis industry as well as the industrial hemp industry.

The current Intellectual Property portfolio consists of all of the rights, title and interest that Dr. Lombardi had in certain two Provisional Patent Applications (collectively, the “Applications”). Assignments of both of these applications, which assign their ownership to High Sierra, have been filed with the United States Patent & Trademark Office. The Applications have since been incorporated into and converted into two all-encompassing Utility Patent Applications which have been filed with numerous governmental agencies in the United States, Canada and multiple other countries in Europe as is discussed below (collectively the “Utility Patent ~~Applications~~Application”). As of the date hereof, there have been two United States Patents issued based on the Utility Patent Application as is also discussed below. As of the date hereof, the Company also has several ongoing Utility Patent Applications in the United States, Europe and Canada.

The Intellectual Property

High Sierra ~~now~~originally ~~owns~~owned two ~~provisional~~Provisional ~~patent~~Patent Applications ~~applications~~ which it acquired from Dr. Lombardi by way of assignments. The first Application, ~~describes~~which was converted into a Utility Patent Application which subsequently became an issued United States Patent (United States Patent Number 10,737,198), describes a new and novel cannabis product that is produced by removing or significantly reducing the naturally occurring compliment of volatile organic molecules from cannabis, which primarily consist of terpenes, and are collectively known as the essential oils. This new and novel cannabis product embodies any product produced from any of the flowering plants of the genus Cannabis, using any convenient method for removing or significantly reducing the naturally occurring compliment of essential oils, and, which at the same time, generally preserves the naturally occurring compliment of cannabinoids in a product that retains the naturally occurring physical structure of cannabis plant material that is normally consumed by way of smoking (combustion and subsequent inhalation) and also leaves the modified harvested cannabis plant material undamaged and still in a condition that it can be smoked in the same manner as before it was modified by the process and/or processes described herein. As used herein, the term “cannabis” includes industrial hemp which is defined as the plant Cannabis sativa L. having a Δ9-tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis (“Hemp”).

The second Application, ~~describes~~which was converted into a Utility Patent Application which subsequently became an issued United States Patent (United States Patent Number 10,835,839), describes a new and novel cannabis product that is produced by further modifying a cannabis product based on the first Application containing cannabis plant material that has been previously modified by removing or significantly reducing the naturally occurring compliment of volatile organic molecules, which primarily consist of terpenes, and are collectively known as the essential oils, so as to create a low, or no, odor and reduced flavor form of cannabis product. The previously modified cannabis product is then subjected to additional modification, or modifications, consisting of the addition of volatile organic molecules, either naturally occurring or synthetically produced, including, but not limited to, essential oils, flavorings or terpenes and terpenoids so as to cause it to have new and unique odors and flavors.

By using the techniques and processes covered by the two Applications and resulting patents, High Sierra can create a low, or no, odor and reduced flavor form of cannabis, which can be used in that state or modified to have new and unique odors and flavors.

High Sierra’s Intellectual Property encompasses the dried cannabis plant material, or flower, that is intended to be smoked, as well as any dried cannabis plant material that is intended to be smoked and to which flavoring is added. It should be noted that this technology is also applicable to the use of hemp-based products that are to be smoked both in non-flavored and flavored forms.

The Applications and the Utility Patent ~~Applications~~ Application are based on the premise that cannabis (also known as marijuana) which is a preparation of the cannabis plant that encompasses at least three genera of flowering plant in the family of Cannabaceae including Cannabis sativa, Cannabis indica and Cannabis ruderalis has a distinct odor and flavor, primarily as a result of several volatile small molecules known as terpenes. These terpenes are also present in the genus of the flowering plant commonly known as hemp. Although the odor and flavor that results from the presence of these terpenes is desirable to many users of cannabis and/or hemp, the strong and pungent odor, as well as the distinctive flavor, is undesirable by others especially due to the fact that the odor lingers after use of cannabis and/or hemp. Additionally, the characteristic odor makes it obvious that a given individual has recently used cannabis and/or hemp. Since a user of hemp is doing so for solely medicinal purposes, High Sierra believes this negative characteristic is of even greater importance to a user of a hemp-based product. Furthermore, the strong and pervasive odor, as well as the distinctive flavor, that results from the presence of these terpenes represents an obstacle for creating a flavored form of cannabis and/or hemp which High Sierra believes to be desirable.

High Sierra has engaged the law firm of Oliff PLC to prosecute its Provisional Patent Applications and its Utility Patent Applications. In January 2019, the two provisional patent Applications were combined into one broad and all-encompassing Utility Patent Application which was filed with the United States Patent and Trademark Office, the Canadian Intellectual Property Office and under the provisions of the Patent Cooperation Treaty (“PCT”) which will afford High Sierra additional temporary protection in an additional 152 other countries. In the United States, this all-encompassing Utility Patent Application was subsequently split into two Utility Patent Applications both of which subsequently resulted in United States Patents being issued.

High Sierra’s current Intellectual Property Applications are specific to the dried cannabis plant material where the characteristic odor and flavor have been removed or significantly reduced as well as products that utilizes the first product. High Sierra believes that its intellectual property may be able to be expanded to include other opportunities in the cannabis and industrial hemp markets. High Sierra is currently attempting to develop such products, independently, and through joint venture arrangements. However, the Company can offer no assurance that High Sierra will be successful in this effort.

~~High~~The ~~Sierra~~Company’s ~~believes~~Patented ~~that~~and itPatent isPending products ~~likely~~and ~~that~~the ~~its~~processes ~~Provisional~~by ~~Patent~~which ~~Applications~~they ~~and~~are ~~the~~generated ~~Utility~~are ~~Patent~~specific ~~Applications~~to ~~will~~modified beforms ~~converted~~of ~~into~~cannabis ~~full~~which ~~Utility~~have ~~Patents~~little inor ~~due~~none ~~course~~of inthe ~~both~~characteristic odors ~~the~~common ~~United~~to ~~States~~cannabis, ~~Canada~~as ~~and~~well ~~numerous~~as ~~countries~~any inmodified ~~Europe.~~or ~~During~~flavored products produced with the ~~time~~previously ~~allowed~~modified ~~under~~cannabis ~~the~~products. ~~provisions~~The ofCompany believes ~~the~~that ~~PCT,~~these ~~High~~products ~~Sierra~~and ~~intends~~processes tomay ~~determine~~also inbe ~~which~~applicable ~~foreign~~to ~~countries~~industrial ithemp ~~will~~as bedefined ~~appropriate~~in tothe ~~file~~Hemp ~~additional~~Farming ~~utility~~Act ~~patent~~of ~~applications~~2018.

The Company’s Patent Pending products and the processes by which they are generated are specific to modified forms of cannabis which have little or none of the characteristic odors common to cannabis, as well as any modified or flavored products produced with the previously modified cannabis products. The Company believes that these products and processes may also be applicable to industrial hemp as defined in the Hemp Farming Act of 2018.

On March 25, 2020, the Company received an International Preliminary Report of Patentability for its Patent Cooperation Treaty Application Number PCT/US2019/014778, CANNABIS PRODUCTS MODIFIED BY REMOVING VOLATILE ORGANIC COMPOUNDS AND ADDING VOLATILE UNSATURATED HYDROCARBONS, in which Claims Numbered 1-84 were characterized as novel and Claims Numbered 1-17, 63-70, 83 and 84 were characterized as inventive steps.

On June 5, 2020, the United States Patent and Trademark Office, by way of an Office Action dated May 29, 2020, notified the Company that Claims Numbered 1-17, 63-70 and 83-84 of Patent Application Number 16/255,157, CANNABIS PRODUCTS MODIFIED BY REMOVING VOLATILE ORGANIC COMPOUNDS AND ADDING VOLATILE UNSATURATED HYDROCARBONS, were now allowed. These are four of the seven main claims in Patent Application Number 16/255,157. In response to this, the Company’s outside Patent Counsel, Oliff PLC, has filed an Amendment to Patent Application Number 16/255,157 so that these Claims can be issued a formal Notice of Allowance which would then lead to the issuance of a Utility Patent for these Claims. As a result of this action by our attorneys at Oliff PLC, on June 19, 2020, the United States Patent and Trademark Office issued a formal Notice of Allowance and Fee(s) Due which will allow the Utility Patent to be issued once the fees are paid. This Patent was issued as United States Patent Number 10,737,198 on August 11, 2020. The Company’s attorneys at Oliff PLC also prepared a Continuation Application for Claims Numbered 18-62 and 71-82 so that the Company can continue to prosecute these Claims separately. This Continuation Application has resulted in the issuance of United States Patent Number 10,835,829 on November 17, 2020.

OnAllowance ~~July~~which ~~23,~~would ~~2020,~~then lead to the ~~Company~~issuance of ~~received~~a anUtility ~~Issue~~Patent ~~Notification~~for ~~from~~these ~~the~~Claims. ~~United~~As ~~States~~a ~~Patent~~result ~~and~~of ~~Trademark~~this ~~Office~~action ~~stating~~by ~~that~~our attorneys at Oliff PLC, on ~~August~~June 1119, 2020, the United States Patent and Trademark Office issued a formal Notice of Allowance and Fee(s) Due which will ~~issue~~allow the Utility Patent to be issued once the fees are paid. This Patent was issued as United States Patent Number 10,737,198 toon ~~the~~August 11, 2020. The Company’s asattorneys ~~assignee~~at ofOliff PLC also prepared a Continuation Application ~~Number~~for ~~16/255.157,~~Claims ~~CANNABIS~~Numbered ~~PRODUCTS~~18-62 ~~MODIFIED~~and BY71-82 ~~REMOVING~~so ~~VOLATILE~~that ~~ORGANIC~~the ~~COMPOUNDS~~Company ~~AND~~can ~~ADDING~~continue ~~VOLATILE~~to ~~UNSATURATED~~prosecute ~~HYDROCARBONS,~~these ~~filed~~Claims separately. byThis ~~Vincent~~Continuation ~~Lombardi,~~Application ~~one~~has ofresulted in the ~~founders~~issuance of ~~the~~United ~~Company~~States ~~and~~Patent ~~its~~Number ~~current~~10,835,829 ~~President~~on ~~and~~November ~~Chief~~17, ~~Executive Officer~~2020.

~~Now~~On ~~United~~August ~~States Patents Numbers 10~~11,~~737,198~~ ~~and 10~~2020,~~835,839~~ ~~have been formally issued,~~ the ~~Company~~United ~~intends~~States toPatent ~~begin actively marketing~~ and Trademark ~~licensing~~Office ~~its~~issued patented technologies in both the cannabis and hemp market spaces as well as pursuing its own uses of its patented technologies in relation to various end user products that can benefit from its patented technologies. In regards to the issuance of United States ~~Patents~~Patent ~~Numbered~~Number 10,737,198 ~~and~~to ~~10.835,839, Vincent C. Lombardi, President and Chief Executive Officer of~~ the Company, ~~has~~as ~~stated~~assignee ~~that “we believe the effect~~ of ~~the~~Application ~~issuance~~Number ~~of Patents Numbered 10~~16/255.157,~~737,~~ ~~198~~CANNABIS ~~and~~PRODUCTS MODIFIED ~~10,~~BY ~~835,839~~REMOVING isVOLATILE ~~that~~ORGANIC itCOMPOUNDS ~~will~~AND ~~allow~~ADDING ~~the~~VOLATILE ~~Company~~UNSATURATED toHYDROCARBONS, befiled ~~able~~by toVincent ~~effectively control the marketplace for low~~Lombardi, orone ~~no,~~of ~~odor cannabis and hemp products in~~ the ~~United~~founders of ~~States which will allow~~ the Company toand ~~start~~its ~~generating~~current ~~licensing~~President ~~revenue~~and ~~from~~Chief ~~the~~Executive ~~technology disclosed in United States Patents Numbered 10,737,198 and 10,835,839~~Officer.”

~~The~~On ~~Company~~November ~~has~~17, ~~received~~2020, athe ~~First~~United ~~Office~~States ~~Action~~Patent and onTrademark ~~its~~Office ~~Canadian~~issued United States Patent Number 10,835,839 to the Company as assignee of Application Number 316/255.157,~~031,123,~~ CANNABIS PRODUCTS MODIFIED BY REMOVING VOLATILE ORGANIC COMPOUNDS AND ADDING VOLATILE UNSATURATED HYDROCARBONS, ~~and~~filed ~~its~~by ~~attorneys~~Vincent atLombardi, ~~Oliff~~one of ~~PLC~~the ~~and~~founders ~~Bereskin~~of &the ~~Parr in Canada have responded to it. The~~ Company ~~has~~and ~~also recently amended~~ its ~~Canadian~~current ~~Patent~~President ~~Application so that it accurately reflects the claims embodied in United States Patents Numbered 10, 737, 198~~ and ~~10,835,839~~Chief asExecutive ~~well as the Continuation Application Number 17,098/539 filed on November 16, 2020~~Officer.

~~The~~Now ~~Company’s~~United ~~outside~~States ~~Patent~~Patents ~~Counsel~~Numbers 10,737,198 ~~Oliff~~and 10,835,839 ~~PLC~~have ~~has~~been ~~completed~~formally ~~the~~issued, ~~Application to~~ the ~~European~~Company ~~Patent~~intends ~~Office (“EPO”)~~to ~~based~~begin onactively ~~Patent~~marketing ~~Cooperation~~and ~~Treaty~~licensing ~~Application~~its ~~Number~~patented ~~PCT/US2019/014778,~~technologies ~~CANNABIS~~in ~~PRODUCTS~~both the ~~MODIFIED~~cannabis BYand ~~REMOVING~~hemp ~~VOLATILE~~market ~~ORGANIC~~spaces ~~COMPOUNDS~~as ~~AND~~well ~~ADDING~~as ~~VOLATILE~~pursuing ~~UNSATURATED~~its ~~HYDROCARBONS. It~~own ~~has~~uses ~~been~~of ~~filed~~its aspatented ~~European~~technologies ~~Patent~~in ~~Office~~relation ~~Application~~to ~~Number~~various ~~19743904.5.~~end ~~The~~user ~~Company~~products that ~~has~~can ~~also~~benefit ~~recently~~from ~~amended~~ its ~~EPO~~patented ~~Application~~technologies. soIn ~~that~~regards itto ~~accurately reflects~~ the ~~claims~~issuance ~~embodied~~of in United States Patents Numbered 10, 737, 198 and 10,.835,839, Vincent asC. ~~well~~Lombardi, asPresident ~~the~~and ~~Continuation~~Chief ~~Application~~Executive ~~Number~~Officer 17of the Company,~~098/539~~ ~~filed~~has onstated ~~November~~that ~~16,~~“we ~~2020.~~believe ~~This~~the ~~EPO~~effect ~~Application~~of the issuance of Patents Numbered 10,737,198 asand ~~amended~~10,835,839 is that it will allow the Company to ~~simultaneously~~be ~~prosecute~~able ~~its~~to ~~PCT~~effectively ~~Application~~control inthe amarketplace ~~total~~for low, ofor 38no, ~~different~~odor ~~countries~~cannabis and hemp products in ~~Europe~~the ~~and~~United States which will allow the ~~surrounding~~Company ~~areas~~to asstart ~~well~~generating aslicensing ~~Hong~~revenue ~~Kong~~from the technology disclosed in United States Patents Numbered 10,737,198 and 10,835,839.”

The Company has received a First Office Action on its Canadian Patent Application Number 3,031,123, CANNABIS PRODUCTS MODIFIED BY REMOVING VOLATILE ORGANIC COMPOUNDS AND ADDING VOLATILE UNSATURATED HYDROCARBONS, and its attorneys at Oliff PLC and Bereskin & Parr in Canada have responded to it. The Company has also recently amended its Canadian Patent Application so that it accurately reflects the claims embodied in United States Patents Numbered 10,737,198 and 10,835,839 as well as the Continuation Application Number 17,098/539 filed on November 16, 2020. The Company has received a Second Office Action to this Amended Canadian Patent Application and, in concert with its attorneys, has recently responded to it.

The Company’s outside Patent Counsel, Oliff PLC has completed the Application to the European Patent Office (“EPO”) based on Patent Cooperation Treaty Application Number PCT/US2019/014778, CANNABIS PRODUCTS MODIFIED BY REMOVING VOLATILE ORGANIC COMPOUNDS AND ADDING VOLATILE UNSATURATED HYDROCARBONS. It has been filed as European Patent Office Application Number 19743904.5. The Company has also recently amended its EPO Application so that it accurately reflects the claims embodied in United States Patents Numbered 10,737,198 and 10,835,839 as well as the Continuation Application Number 17,098/539 filed on November 16, 2020. This EPO Application, as amended, will allow the Company to simultaneously prosecute its PCT Application in a total of 44 different countries in Europe and the surrounding areas as well as Hong Kong. The Company has received a First Office Action to its European Patent Office Application Number 19743904.5. The Company and its attorneys at Oliff PLC and Astrum Element One Limited in the United Kingdom are in the process of preparing a response to it.

On February 8, 2022, the United States Patent and Trademark Office issued a Notice of Allowance for the Company’s Continuation Application No. 17/098,539 which was filed on November 16, 2020. Once the filing fee is paid, the Letters Patent will issue and the Company will then have a third United States Patent.

The Company is in the process of preparing a Continuation in Part Application for Continuation Application No. 17/098,539 which should result in the Company receiving a fourth United States Patent in due time.

Marketing Plans to License the Intellectual Property

High Sierra is now marketing the licensing of its technology in states in the U.S. where cannabis and/or hemp has been legalized both for medicinal and/or recreational use. It also plans to use a similar marketing strategy in all provinces in Canada which ~~has~~have legalized both the medicinal and recreational uses of cannabis as of October 17, 2018. Hemp has long been legal in Canada. High Sierra is targeting entities that are licensed to produce, process and/or manufacture cannabis and/or hemp related products. High Sierra also believes that its technology will be of interest to tobacco companies in the United States, Canada and other places if those companies choose to enter the cannabis and/or hemp marketplaces as the legalization of cannabis and/or hemp progresses.

High Sierra considers every manufacturer of cannabis and/or hemp products a potential customer. Because each is registered with its respective State and are of public record, High Sierra has begun to identify each manufacturer for a direct marketing campaign. High Sierra plans to aggressively exploit what it believes to be niche areas of the cannabis and/or hemp markets that are not currently being addressed.

Presently, manufacturers of cannabis and/or hemp products are limited to selling low-odor cannabis and/or hemp for smoking, as an extract, and are limited to selling flavored product either as an extract for smoking or edibles. While it is possible to produce a flavored dried plant form without first removing the natural complement of terpenes, High Sierra believes that the strong natural smell and flavor makes it impractical to add additional flavoring other than additional terpenes.

Because low odor or no odor cannabis and/or hemp plant material products for smoking are novel and currently do not exist, it is High Sierra’s goal to create a market for such products by demonstrating their utility and desirability. Low-odor cannabis and/or hemp plant material allows one to smoke cannabis and/or hemp without its use being apparent due to the residual smell on the user. It also allows the user the convenience of smoking cannabis and/or hemp in the form of a rolled cigarette or a pipe. Because low-odor and flavored cannabis and/or hemp plant material can be conveniently made into cigarettes, it is High Sierra’s belief that as cannabis and/or hemp gain acceptance according to local and Federal laws, that the large tobacco companies will want to enter the cannabis and/or hemp market spaces and will rely on their present business model of selling cigarettes that are pre-packaged. These companies are all potential clients to license High Sierra’s technology.

7Artemis Holdings Agreement

~~market~~On ~~spaces~~October 14, 2020, we entered into an exclusive Letter Agreement with Artemis Holdings, LLC pursuant to which Artemis Holdings, LLC was to assist us in maximizing the value of our patents and ~~will~~patents ~~rely~~pending onfor ~~their~~odorless ~~present~~cannabis. ~~business~~Artemis ~~model~~was to provide a detailed market analysis of ~~selling~~the ~~cigarettes~~patents ~~that~~and ~~are~~to ~~pre-packaged~~assist with any licensing or sale of the patents. ~~These~~The ~~companies~~agreement ~~are~~was ~~all~~for ~~potential~~a ~~clients~~period of nine months, and then it automatically renewed for additional one month periods until either party terminated it. The Company agreed to pay Artemis a fee of $5,000 per month during the term, and a transaction fee of 7.5% of the gross proceeds of any transaction (sale, license, ~~High~~etc.) ~~Sierra’s~~arranged ~~technology~~by Artemis. The parties mutually agreed to terminate the agreement effective April 1, 2021, and neither party owes any further obligations to the other following the termination.

On October 14, 2020, we entered into an exclusive Letter Agreement with Artemis Holdings, LLC pursuant to which Artemis Holdings, LLC is to assist us in maximizing the value of our patents and patents pending for odorless cannabis. Artemis is to provide a detailed market analysis of the patents and to assist with any licensing or sale of the patents. The agreement is for a period of nine months, and then it automatically renews for additional one month periods until either party terminates it. The Company will pay Artemis a fee of $5,000 per month during the term, and a transaction fee of 7.5% of the gross proceeds of any transaction (sale, license, etc.) arranged by Artemis. A copy of the Letter Agreement is attached to our Quarterly Report on Form 10-Q for the period ended September 30, 2020 as Exhibit 10.22.

Consulting Agreement

On August 14, 2020, we entered into a non-exclusive Consulting Agreement with Stanley Berk/Steven Leatherman (“SBSL Consultants”) and Jeff Baclet/Tom Prutzman (“Consultants”) pursuant to which the SBSL Consultants and other Consultants agreed to review short term and long term business forecasts for the Company, review documents for due diligence purposes, seek out private and public funding for the Company, and seek out potential licensing partners and potential buyers of the Company’s intellectual property. They referred the Company to Artemis Holdings, LLC. See above. ~~The~~ The term of the Agreement was for six months. The Company agreed to pay a consulting fee of $7,500 per month (to be deferred until the Company has raised at least $500,000), and 5.0% of funds raised from any source brought to the Company by the Consultants. The Consultants were also granted warrants to purchase 5.0% of the securities sold in such fundraising at the same price, which is exercisable for a period of 5 years. This August 14, 2020 Consulting Agreement was amended on December 28, 2020 to now be effective as of January 1, 2021. Under the terms of this amendment the term of the Agreement became one year ending on December 31, 2021. The consulting fees were reduced to $1,200.00 per month, a potential bonus of $45,000 was incorporated, the referral fees were reduced to 2% and the warrants to be issued were set at to 2.5% of the value of certain transactions caused by Admiral Investment Banking and 2% of the value of certain transactions caused by Artemis Holdings Group, LLC. A copy of this Amended Consulting Agreement is attached hereto as Exhibit 10.8.

period of 5 years. This August 14, 2020 Consulting Agreement was amended on December 28, 2020 and became effective on January 1, 2021. Under the terms of this amendment the term of the Agreement became one year ending on December 31, 2021. The consulting fees were reduced to $1,200 per month, a potential bonus of $45,000 was incorporated, the referral fees were reduced to 2% and the warrants to be issued were set at to 2.5% of the value of certain transactions caused by Admiral Investment Banking and 2% of the value of certain transactions caused by Artemis Holdings Group, LLC. A copy of the Amended Consulting Agreement is attached to our Annual Report for the year ended December 31, 2020 as Exhibit 10.7. This Agreement terminated on its own terms on December 31, 2021 and the parties have no further obligations to each other.

Admiral Investment Banking Agreement

On December 28, 2020 the Company entered into an Agreement with Admiral Investment Banking (“Admiral”) to market our Private Placement Offering of 2,000,000 shares of common stock to accredited investors. The Agreement iswas for the period of one year and ~~has~~had certain renewal provisions. The Agreement ~~provides~~ provided for commissions of 8% of monies generated by Admiral to be paid to Admiral. It also ~~provides~~provided for an override of 2% to be payable to Admiral in the event of the inclusion of another broker/dealer in a transaction. The Agreement also ~~provides~~provided for the issuance of warrants to Admiral or its principals in certain instances if so designated by Admiral. The warrants are exercisable at $0.01 per share for a period of five (5) years after the issuance date and cover a total of 50,000 shares. The Company gave notice to Admiral on October 8, 2021 that the Company was terminating the Agreement effective as of November 10, 2021, but the outstanding warrants are still in effect.

~~Failure~~Possible ~~of Industrial~~ Hemp ~~Farming~~Cigarette ~~Crop~~Business ~~and Activities~~

~~In 2019~~ High Sierra ~~entered~~has ~~into~~identified a ~~Lease~~growing ~~Agreement~~market place for ~~the~~hemp ~~use~~cigarettes ofespecially ~~200~~those ~~acres~~that ofcan ~~land~~benefit infrom ~~McDermitt,~~High ~~Nevada~~Sierra’s topatented beand ~~used~~patent aspending antechnologies. ~~experiment~~It ~~for~~is ~~determining~~ the ~~viability~~ intention of ~~operating a large-scale hemp farming concern. Concurrently with the execution of the Lease Agreement,~~ High Sierra ~~also~~to ~~entered~~enter into athis ~~Consulting~~market ~~Agreement~~place ~~with~~as ~~the~~soon ~~owner~~as ofpossible ~~the~~after ~~land~~it ~~for~~receives ~~his~~sufficient ~~services~~funding infrom ~~managing~~its ~~the~~Private ~~farming~~Placement ~~activities~~Offerings. To Inthat ~~approximately November 2019~~effect, ~~management~~the ~~determined~~Company ~~that~~is itnow ~~was~~negotiating ~~not~~with inone of the ~~best~~largest ~~interest~~hemp ofcigarette ~~High~~manufacturers ~~Sierra~~in tothe ~~continue~~country to ~~spend~~enter ~~money~~into ona ~~the~~joint venture ~~farm due~~ to ~~the~~produce ~~failure~~and ofmarket ~~the~~a ~~crop. The~~new ~~failure~~brand of ~~the~~low ~~crop~~odor ~~was,~~hemp ~~largely~~cigarettes. ~~due~~The tonegotiations ~~inconsistencies~~have resulted in the ~~quality~~execution of ~~seeds~~a ~~that~~non-binding Letter ~~are~~of ~~commercially~~Intent ~~available~~dated asFebruary ~~well~~18, as2022, ~~logistical~~by ~~issues~~the ~~with~~parties ~~respect~~ to ~~managing~~enter ~~farming~~into ~~activities. The~~a ~~hemp~~Joint ~~seeds~~Venture ~~purchased~~to ~~and~~manufacture, ~~planted~~market byand ~~the~~distribute ~~Company~~hemp ~~had~~cigarettes and ~~the~~hemp-based ~~following~~products ~~three~~in ~~basic~~the ~~problems:~~United ~~(a)~~States, ~~too~~Canada ~~many~~and ~~male~~Mexico ~~plants~~using ~~were~~its ~~produced~~Patented and ~~male~~Patent ~~plants~~Pending ~~produce~~Technologies. ~~little~~The orCompany can offer no ~~CBD;~~assurance ~~(b)~~that ~~one-third~~it ofwill ~~the~~successfully ~~crop~~raise ~~was~~the ~~too~~funds ~~high~~needed into ~~its~~enter ~~THC~~into ~~content~~this ~~and~~market ~~had~~place. toThe beCompany ~~destroyed;~~is ~~and~~in ~~(c)~~ the ~~resulting~~process ~~crop~~of ~~that~~negotiating definitive ~~could~~agreements berelated ~~harvested~~to ~~had~~this ~~very~~Letter ~~little~~of ~~biomass with a very low CBD content.~~ Intent

High Sierra is now in the process of determining the best use of the equipment that was purchased for use in the farming activities.\

High Sierra has identified a growing market place for hemp cigarettes especially those that can benefit from High Sierra’s patented and patent pending technologies. It is the intention of High Sierra to enter into this market place as soon as possible after it receives sufficient funding from its Private Placement Offerings. The Company can offer no assurance that it will successfully raise the funds needed to enter into this market place.

General Information Concerning Cannabis and Hemp and Related Regulatory Laws

Currently, cannabis is consumed in three forms. The dried plant material that is smoked, extracts of cannabis that are smoked using devices such as e-cigarettes, and cannabis consumables. Hemp based products may also be consumed by these same three methods as well as being used as a topical application to the skin. High Sierra’s Intellectual Property is currently specific for dried cannabis plant material, including hemp, which is intended to be consumed by smoking which High Sierra believes to be the largest segment of the cannabis related market.

Recreational cannabis is now currently legal in 18 ~~eleven~~ states and the District of Columbia and medicinal cannabis is legal in 3335 states, the District of Columbia, Guam and Puerto Rico. Thirteen states and the U.S. Virgin Islands have passed laws decriminalizing cannabis in some form. In addition, Canada has legalized both medicinal and recreational cannabis in all provinces as of October 17, 2018. Hemp, which is defined as cannabis, with a tetrahydrocannabinol (THC) content of less than 0.3%, has long been legalized in Canada. It should be noted that cannabis continues to be illegal at the Federal level in the United States. It should be further noted that, with the President’s signature on the Hemp Farming Act of 2018 that was passed overwhelmingly by Congress, the non-psychoactive components of cannabis, such as cannabidiol will become legal in all states and will cease to be controlled substances that come under the authority of the Food and Drug Administration.

With the enactment on December 20, 2018 of the Hemp Farming Act of 2018, hemp and/or cannabidiol based products are no longer classified as controlled substances. High Sierra believes that its technology will also be readily applicable to hemp and/or cannabidiol based products that may be consumed via combustion and subsequent inhalation and/or ingestion in various forms. Because there are currently known uses of hemp and/or cannabidiol products that use combustion and subsequent inhalation as a method of consumption, High Sierra believes that such producers and users of these products will see a similar advantage to the use of High Sierra’s technologies as do the producers and users of medical and recreational cannabis products that are consumed via combustion and subsequent inhalation and/or ingestion in various forms.

inhalation and/or ingestion in various forms. Because there are currently known uses of hemp and/or cannabidiol products that use combustion and subsequent inhalation as a method of consumption, High Sierra believes that such producers and users of these products will see a similar advantage to the use of High Sierra’s technologies as do the producers and users of medical and recreational cannabis products that are consumed via combustion and subsequent inhalation and/or ingestion in various forms.

Because High Sierra’s business model is based on (1) the licensing of its technology, and (2) the production and marketing of hemp cigarettes using its various patented and patent pending technologies, it is not necessary for High Sierra to handle, sell or distribute cannabis in order to benefit from the rapidly expanding cannabis market. Accordingly, High Sierra is not directly subject to the limitations imposed by these existing Federal laws in the United States as they may relate to cannabis. With the enactment on December 20, 2018 of the Hemp Farming Act of 2018, hemp-based products have ceased to be controlled substances that come under the authority of the Drug Enforcement Administration thus providing High Sierra an opportunity in a new marketplace that is not subject to the same level of Federal regulation as is the marijuana form of cannabis. This puts High Sierra in a unique position to benefit from the rapidly expanding cannabis and hemp industries, while at the same time, not being directly subject to the Federal controlled substance laws of the United States.

Market Place Overview

According to a report by the Brightfield Group, the global cannabis market is currently estimated to be worth $7.7 billion and will likely experience a compound annual growth rate of 60 percent as other countries liberalize their marijuana laws. It should also be noted that Wall Street analysts have projected that the change in the laws related to cannabis in Canada could create as much as $5 billion in additional sales. The international market for cannabis is projected to hit $3151.41 billion by ~~2021, according to a report from the Brightfield Group~~2025. ~~Cowen~~ &New ~~Co.~~Frontier Data has estimated that ~~U.S.~~North American cannabis sales could reach $75 35.2 billion byin ~~2030. Furthermore,~~2022 ~~a report by the European investment bank Bryan, Garnier & Co., projects legal global cannabis market will grow by more than 1,000% over the next decade~~ and ~~could reach~~ $~~140~~49.0 billion by ~~2027~~2025.

~~According to 2016 statistics reported by the State of Washington, sales of cannabis flower represented 61% of total cannabis product sales. Because of the new and novel nature of~~ High Sierra’s product, it’s difficult to estimate the potential market; however, if one assumes that cigarette sales statistics are a reflection of potential cannabis sales, methanol cigarette sales are estimated to represent 30% of total tobacco sales (Lorillard, Inc. 2012 Form 10-K, p. 40. U.S. Securities and Exchange Commission). High Sierra believes that cannabis products that employ its technology (with respect to utilizing unflavored product as the starting material to make a flavored product) will create a significant addition to the existing cannabis markets. High Sierra further believes that it is reasonable to project a similar percentage of flavored cannabis sales as opposed to non-flavored cannabis sales (30%). If trends for tobacco cigarettes are an indication of future cannabis cigarette sales, flavored cannabis cigarettes could represent a market of $18.484 billion (based on $729.74 billion total ~~2016~~2021 cannabis sales~~, 61% cannabis flower sales, and 30% flavored cannabis sales~~). High Sierra believes that it may earn significant licensing revenue from licensing its existing technology, based on its proposed 10% licensing fee. If large tobacco companies enter the cannabis marketplace, they are likely to represent a new and highly significant licensing revenue source for High Sierra.

Of the five Western states that have legalized cannabis, the first-year sales for each state were significant. Nevada had first year sales of approximately $425 million (based on only 6 months of sales in 2017), Colorado had first year sales of approximately $303 Million, Washington had first year sales of approximately $259 million and Oregon had first year sales of approximately $241 million. According to BDS Analytics, it is projected that California will have sales in excess of $3.7 billion it its first year of legalization (2018). Additionally, Colorado reported 2017 sales of approximately $1.5 billion, Washington reported 2017 sales of approximately $1.3 billion and Oregon reported 2017 sales of approximately $500 million (based on recreational dispensary sales only. According to projections by BDS Analytics and Acrview Market Research, the market for cannabis-based products approached nearly $10 billion in 2017 which represents a 33% increase over 2016. Both companies indicate that this percentage of annual increase will continue to grow based on more states legalizing cannabis for recreational use and the recent change in the laws in Canada that went into effect on October 17, 2018.

Currently, companies such as Canopy Growth, Cronos Group and Tilray which are based in Canada have begun to be traded both on the NASDAQ and the New York Stock Exchange. Constellation Brands has recently invested $4 billion in Canopy Growth based on its belief in the strong future for the market place for cannabis.

It should be noted that none of these statistics or projections include products based on the non-psychoactive components of cannabis, such as hemp and/or cannabidiol. These are markets that Statista has estimated will grow from $108 million in 2014 to $1.5 billion in 2022. In ~~2016, Forbes predicted that these markets are likely to grow 700% by 2020.~~ High Sierra believes that its opportunities will be increased with its proposed entrance into the non-psychoactive components of cannabis, such as hemp and/or cannabidiol marketplaces.

Potential Acquisition

On December 28, 2021, the Company executed a non-binding Letter of Intent to acquire an Oregon Corporation specializing in hemp-related products in a Share Exchange Transaction pursuant to 26 U.S.C. §368. This Letter of Intent was subsequently amended on January 22, 2022.

Competition

High Sierra is not aware of any other companies that are working on similar technology that can be applied to cannabis and/or hemp flower products to remove or significantly reduce the odor and flavor of such products which are consumed by smoking and/or ingestion. However, High Sierra believes that eventually there may be competitors. High Sierra believes that it will have an early competitive advantage being the first to enter this line of business and file for patent protection as has been discussed in other places herein. It believes that its Provisional Patent Applications and its Utility Patent ~~Applications~~Application, if granted, will give High Sierra some significant protection from competing companies.

There are numerous other companies and individuals that compete in the hemp cigarette market place. Some of those companies are substantially larger than we are and some may have much greater financial resources than we do. We can offer no assurance that we will be able to compete successfully against our competitors in this line of business.

Employees

As of the date of this Report, we have only four part-time employees who are our officers Vincent C. Lombardi, Gregg W. Koechlein, Jeffrey M. Pogol and Glenn C. Miller, and no full time employees. Mr. Lombardi, Mr. Koechlein and Mr. Pogol each devote approximately sixteen (16) hours per week to the business of the Company, and Mr. Miller devotes approximately eight (8) hours per week to the business of the Company. They may be compensated for their part time services on an as needed basis. For example, on February 26, 2021, we issued 10,000 shares of our restricted common stock to Jeffrey M. Pogol and 10,000 shares of our restricted common stock to another service provider for services rendered valued in the amount of $2,000 each, and on January 1, 2021 Gregg W. Koechlein was paid $7,500 for services. On November 12, 2021 Gregg Koechlein was also paid $5,000.00 for services. We have no written employment agreements. We have never experienced a work stoppage and believe our relationship with our employees is good.

Effect of Existing or Probable Governmental Regulations on our Business

We are subject to the following regulations of the SEC and applicable securities laws, rules and regulations:

Smaller Reporting Company

We are subject to the reporting requirements of Section 13 of the Exchange Act, and subject to the disclosure requirements of Regulation S-K of the SEC, as a “smaller reporting company.” That designation will relieve us of some of the informational requirements of Regulation S-K applicable to larger companies.

Sarbanes/Oxley Act

We are also subject to the Sarbanes/Oxley Act of 2002. The Sarbanes/Oxley Act created a strong and independent accounting oversight board to oversee the conduct of auditors of public companies and strengthen auditor independence. It also requires steps to enhance the direct responsibility of senior members of management for financial reporting and for the quality of financial disclosures made by public companies; establishes clear statutory rules to limit, and to expose to public view, possible conflicts of interest affecting securities analysts; creates guidelines for audit committee members’ appointment, compensation and oversight of the work of public companies’ auditors; management assessment of our internal controls; auditor attestation to management’s conclusions about internal controls; prohibits certain insider trading during pension fund blackout periods; requires companies and auditors to evaluate internal controls and procedures; and establishes a federal crime of securities fraud, among other provisions. Compliance with the requirements of the Sarbanes/Oxley Act will substantially increase our legal and accounting costs.

1012

financial reporting and for the quality of financial disclosures made by public companies; establishes clear statutory rules to limit, and to expose to public view, possible conflicts of interest affecting securities analysts; creates guidelines for audit committee members’ appointment, compensation and oversight of the work of public companies’ auditors; management assessment of our internal controls; auditor attestation to management’s conclusions about internal controls; prohibits certain insider trading during pension fund blackout periods; requires companies and auditors to evaluate internal controls and procedures; and establishes a federal crime of securities fraud, among other provisions. Compliance with the requirements of the Sarbanes/Oxley Act will substantially increase our legal and accounting costs.

Exchange Act Reporting Requirements

Section 14(a) of the Exchange Act requires all companies with securities registered pursuant to Section 12(g) of the Exchange Act to comply with the rules and regulations of the SEC regarding proxy solicitations, as outlined in Regulation 14A. Matters submitted to stockholders at special or annual meetings thereof or pursuant to a written consent will require us to provide our stockholders with the information outlined in Schedules 14A or 14C of Regulation 14; preliminary copies of this information must be submitted to the SEC at least 10 days prior to the date that definitive copies of this information are forwarded to our stockholders.

We are also required to file Annual Reports on SEC Form 10-K and Quarterly Reports on SEC Form 10-Q with the SEC on a regular basis, and will be required to timely disclose certain material events (e.g., changes in corporate control; acquisitions or dispositions of a significant amount of assets other than in the ordinary course of business; and bankruptcy) in a Current Report on SEC Form 8-K.

Emerging Growth Company

We are and we will remain an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012(the “JOBS Act”), until the earliest to occur of (i) the last day of the fiscal year during which our total annual revenues equal or exceed $1 billion (subject to adjustment for inflation), (ii) the last day of the fiscal year following the fifth anniversary of the completion of this primary offering, (iii) the date on which we have, during the previous three-year period, issued more than $1 billion in non-convertible debt securities, or (iv) the date on which we are deemed a "large accelerated filer" (with at least $700 million in public float) under the Exchange Act.

As an "emerging growth company", we may take advantage of specified reduced disclosure and other requirements that are otherwise applicable generally to public companies. These provisions include:

· only two years of audited financial statements in addition to any required unaudited interim financial statements with correspondingly reduced “Management’s Discussion and Analysis” disclosure;

~~only~~· ~~two years of audited financial statements in addition to any required unaudited interim financial statements with correspondingly~~ reduced ~~“Management’s~~disclosure ~~Discussion~~about ~~and~~our ~~Analysis”~~executive ~~disclosure~~compensation arrangements;

· no requirement that we hold non-binding advisory votes on executive compensation or golden parachute arrangements; and

~~reduced~~· ~~disclosure~~exemption ~~about~~from the auditor attestation requirement in the assessment of our ~~executive~~internal ~~compensation~~control ~~arrangements;~~over financial reporting.

no requirement that we hold non-binding advisory votes on executive compensation or golden parachute arrangements; and

exemption from the auditor attestation requirement in the assessment of our internal control over financial reporting.

We have taken advantage of some of these reduced burdens, and thus the information we provide stockholders may be different from what you might receive from other public companies in which you hold shares. In addition, Section 107 of the JOBS Act also provides that an emerging growth company can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. In other words, an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. However, we are choosing to “opt out” of such extended transition period, and as a result, we will comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. Section 107 of the JOBS Act provides that our decision to opt out of the extended transition period for complying with new or revised accounting standards is irrevocable.

Notwithstanding the above, we are also currently a “smaller reporting company”, meaning that we are not an investment company, an asset-backed issuer, or a majority-owned subsidiary of a parent company that is not a smaller reporting company and have a public float of less than $75 million and annual revenues of less than $50 million during the most recently completed fiscal year. In the event that we are still considered a “smaller reporting company”, at such time as we cease being an “emerging growth company”, the disclosure we will be required to provide in our SEC filings will increase, but will still be less than it would be if we were not considered either an “emerging growth company” or a “smaller reporting company”. Specifically, similar to “emerging growth companies”, “smaller reporting companies” are able to provide simplified executive compensation disclosures in their filings; are exempt from the provisions of Section 404(b) of the Sarbanes-Oxley Act (“SOX”) requiring that independent registered public accounting firms provide an attestation report on the effectiveness of internal control

1113

~~independent registered public accounting firms provide an attestation report on the effectiveness of internal control~~ over financial reporting; and have certain other decreased disclosure obligations in their SEC filings, including, among other things, only being required to provide two years of audited financial statements in annual reports.

Start-up Stage

The Company is in the start-up stage and has generated no revenue as of the date hereof. In the past three (3) years, we have been funded primarily through loans from non-related third parties, our officers, directors and our shareholders and through the sale of Notes and Shares of our common stock.

Cost and Effects of Compliance with Environmental Laws

Our current business operations are not subject to any material environmental laws, rules or regulations that would have an adverse material effect on our business operations or financial condition or result in a material compliance cost.

ITEM 1A. RISK FACTORS

As a smaller reporting company, we are not required to provide risk factors; however, for information on risk factors, see the Risk Factors section of our Form 8-K Current Report dated December 31, 2018 and previously filed with the SEC on January 2, 2019.

ITEM 1B. UNRESOLVED STAFF COMMENTS

None

ITEM 2: PROPERTIES

The Company’s ~~only~~has ~~place~~two places of business. The corporate office is located at 1495 Ridgeview Drive, Suite 230A, Reno, Nevada 89519. The space at that location rented by the Company consists of office space with a fixed monthly payment for rent and utilities. The Company is also leasing a research and development and warehousing facility located at 229 East 5th Street in Reno, Nevada 89512.

On November 9, 2021, the Company entered into a Lease Agreement with 3 Squirrels, LLC to rent approximately 1,475 square feet of commercial space which the Company plans to use for research and development purposes. Due to the inability of the Landlord to deliver the Premises as called for in the Lease Agreement on time, a First Amendment to that Lease was signed on January 30, 2022 which changed some terms in the original Lease. The Lease is now for a period of one (1) year commencing February 1, 2022, and contains options for two (2) additional years. The monthly rent is $1,253.75 plus $203.50 in estimated CAM charges. A copy of the Lease Agreement is attached to our Quarterly Report for the period ended September 30, 2021 as Exhibit 10.15 and a copy of the First Lease Amendment is attached to this Annual Report as Exhibit 10.16.

ITEM 3: LEGAL PROCEEDINGS

We are not a party to any pending legal proceeding and, to the knowledge of our management; no federal, state or local governmental agency is presently contemplating any proceeding against us. No director, executive officer or affiliate of ours or owner of record or beneficially of more than 5% of our common stock is a party adverse to us or has a material interest adverse to us in any proceeding.

ITEM 4: MINE SAFETY DISCLOSURES

None; not applicable.

PART II

ITEM 5: MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Market Information

There is no “established trading market” for our shares of common stock. Our shares of common stock are listed on the OTC Bulletin Board of the Financial Industry Regulatory Authority, Inc. (“FINRA”) under the symbol “~~GLFO~~HSTI;” however, management does not expect any established trading market to develop in our shares of common stock unless and until we have material operations. In any event, no assurance can be given that any market for our common stock will develop or be maintained. If a public market ever develops in the future, the sale of shares of our common stock that are deemed to be “restricted securities” pursuant to Rule 144 of the SEC by members of management or others may have a substantial adverse impact on any such market. See the heading “Rule 144” below for requirements of resales of shares of our common stock under Rule 144.

There has been no established trading market in our common stock for many years. Additionally, many of the approximately 8,~~289~~821,~~642~~311 shares issued to non-affiliates in the acquisition of our wholly-owned subsidiary ~~became~~have now become saleable ~~under~~at ~~Rule~~various ~~144~~times inunder ~~January~~Rule ~~2020~~144, and may now be sold into any trading market that may develop for our shares. These factors may result in uncertainty and volatility in the trading price of our common stock that may not have any relation to our current or future prospects.

12Set forth below are the high and low closing bid prices for our common stock for each quarter of 2020 and 2021. These bid prices were obtained from OTC Markets, Inc. and/or OTCQB. The Company became listed on the OTCQB Exchange on December 6, 2021. All prices listed herein reflect inter-dealer prices, without retail mark-up, mark-down or commissions and may not represent actual transactions.

Set forth below are the high and low closing bid prices for our common stock for each quarter of 2020 and 2019. These bid prices were obtained from OTC Markets, Inc. All prices listed herein reflect inter-dealer prices, without retail mark-up, mark-down or commissions and may not represent actual transactions.

Period	High	Low
January 1, 2020 through March 31, 2020	$1.57	$1.00
April 1, 2020 through June 30, 2020	$2.02	$1.57
July 1, 2020 through September 30, 2020	$3.87	$1.77
October 1, 2020 through December 31, 2020	$4.57	$3.87
January 1, 2021 through March 31, 2021	$4.90	$4.57
April 1, 2021 through June 30, 2021	$4.57	$3.50
July 1, 2021 through September 30, 2021	$3.50	$3.50
October 1, 2021 through December 31, 2021	$3.50	$2.75

Period	High	Low
January 1, 2020 through March 31, 2020	$1.57	$1.00
April 1, 2020 through June 30, 2020	$2.02	$1.57
July 1, 2020 through September 30, 2020	$3.87	$1.77
October 1, 2020 through December 31, 2020	$4.57	$3.87
January 1, 2098 through March 31, 2019	$1.25	$1.25
April 1, 2019 through June 30, 2019	$1.25	$1.25
July 1, 2019 through September 30, 2019	$1.25	$1.25
October 1, 2019 through December 31, 2019	$1.25	$1.25

Rule 144

The following is a summary of the current requirements of Rule 144:

Affiliate or Person Selling on Behalf of an Affiliate

Non-Affiliate (and has not been an Affiliate During the Prior Three Months)

Restricted Securities of Reporting Issuers

During six-month holding period – no resales under Rule 144 Permitted.

After Six-month holding period – may resell in accordance with all Rule 144 requirements including:

· Current public information,

· Volume limitations,

· Manner of sale requirements for equity securities, and

· Filing of Form 144.

During six- month holding period – no resales under Rule 144 permitted.

After six-month holding period but before one year – unlimited public resales under Rule 144 except that the current public information requirement still applies.

After one-year holding period – unlimited public resales under Rule 144; need not comply with any other Rule 144 requirements.

Restricted Securities of Non-Reporting Issuers

During one-year holding period – no resales under Rule 144 permitted.

After one-year holding period – may resell in accordance with all Rule 144 requirements including:

· Current public information,

· Volume limitations,

· Manner of sale requirements for equity securities, and

· Filing of Form 144.

During one-year holding period – no resales under Rule 144 permitted.

After one-year holding period – unlimited public resales under Rule 144; need not comply with any other Rule 144 requirements.

Shell Companies

Rule 144 is generally unavailable for the resale of shares of stock of publicly reporting shell companies. After such a company ceases to be a shell company, then Rule 144 may become available for the resale of its outstanding shares beginning 12 months after it files “Form 10 information” with the SEC. We believe that we are no longer a shell company following the closing of our acquisition of our High Sierra subsidiary, and that Rule 144 became available one (1) year following the filing of our Current Report on Form 8-K which was filed on January 2, 2019. We believe that many of the approximately 8,289,642 shares issued to non-affiliates in the acquisition of our wholly-owned subsidiary became saleable under Rule 144 in January 2020, and may now be sold into any trading market that may develop for our shares.

Section 4(a)(1) of the Securities Act

Since we were a shell company as defined in subparagraph (i) of Rule 144 up until December 31, 2018 when we acquired our High Sierra subsidiary, our shares of common stock that were issued while or after we became a shell company were not able to be publicly resold under Rule 144 until approximately January 2, 2020, one (1) year following the filing of our Current Report on Form 8-K which was filed on January 2, 2019.

Holders

We currently have approximately 6974 stockholders, not including an indeterminate number who may hold shares in “street name”.

Dividends

We have not declared any cash dividends with respect to our common stock, and do not intend to declare dividends in the foreseeable future. Our future dividend policy cannot be ascertained with any certainty, and if and until we determine to engage in any business or we complete any acquisition, reorganization or merger, no such policy will be formulated. There are no material restrictions limiting, or that are likely to limit, our ability to pay dividends on our securities.

Securities Authorized for Issuance under Equity Compensation Plans

Plan Category	Number of Securities to be issued upon exercise of outstanding options, warrants and rights	Weighted-average exercise price of outstanding options, warrants and rights	Number of securities remaining available for future issuance under equity compensation plans excluding securities reflected in column (a)
	(a)	(b)	(c)
Equity compensation plans approved by security holders	None	None	None
Equity compensation plans not approved by security holders	None	None	None
Total	None	None	None

Recent Sales of Unregistered Securities; Use of Proceeds from Registered Securities

During the last two (2) years, we have not issued any unregistered securities other than the following:

1. In the three month period ended September 30, 2020, we sold 73,333 shares of our restricted common stock to a total of three investors for total proceeds of $110,001. In the three months ended December 31, 2020 we sold 33,334 shares of our restricted common stock to one investor for total proceeds of $50,000. The shares were sold in reliance on the exemption in Section 4(2) of the Securities Act of 1933 for transactions not involving any public offering. The certificates representing the shares bear a restricted legend, and the persons acquiring the shares represented that they acquired the shares with investment intent.

~~The~~2. ~~Company~~In ~~issued~~the ~~100~~three months ended December 31,~~000~~ ~~shares~~2020, ofwe ~~its~~sold ~~common~~three ~~stock~~Series ~~for~~2 ~~consulting~~Senior ~~services~~Convertible Secured Promissory Notes in the respective amounts of $10,000 (on ~~May~~October 2623, ~~2019~~2020), ~~valued~~$10,000 at(on October 23, 2020) and $~~100~~30,000 (on November 2, ~~which~~2020) ~~was~~to ~~the~~three ~~fair~~investors. ~~market~~A ~~value~~form of the ~~stock~~Series 2 Senior Convertible Secured Promissory Note is attached hereto as Exhibit 10.09. The ~~shares~~Notes ~~were~~bear ~~not~~interest ~~registered~~at ~~under~~8.0% ~~the~~per ~~Securities~~annum, ~~Act~~have a three year term, and the Maturity Dates are automatically extended for successive six month periods in ~~reliance~~the ~~upon~~event the ~~exemption~~Company has not raised gross proceeds from ~~registration~~its ~~provided~~October by1, ~~Section~~2020 ~~4(2)~~private offering or financing from any other source or sources of ~~the~~at ~~Securities~~least ~~Act~~$1,000,000. ~~which~~Each ~~exempts~~Note ~~transactions~~is bysecured anon ~~issuer~~a ~~not~~pro ~~involving~~rata ~~any~~basis ~~public~~with ~~offering~~the other Notes by the assets of the Company. ~~The~~ Each Note is automatically converted into shares ~~received~~of our common stock at a ~~restricted~~price ~~legend~~of $1. 50 per share once we have generated gross proceeds of $1,000,000 from the October 1, 2020 private offering or financing from any other source or sources. The ~~agreement~~holders ~~was~~of ~~later~~the ~~rescinded~~Notes ~~and~~may also voluntarily convert the balances owed under the Notes at an earlier time at the same conversion price of $1.50 per share. Each Note holder will also be issued warrants to purchase shares of our restricted common stock ~~were~~at ~~returned~~$1.50 onper ~~December~~share 30at the time of conversion in an amount equal to 50% of the face amount of the Note, ~~2019~~which ~~and~~are ~~cancelled~~exercisable for a period of three years.

2.17

~~The~~3. On February 26, 2021, the Company issued ~~100~~10,000 shares of its restricted common stock ~~for~~to ~~product~~its ~~(seeds)~~Vice onPresident ~~May~~Jeffrey 26M. Pogol, ~~2019~~and 10,000 shares of its restricted common stock to another service provider, for services rendered which were valued at $~~100~~2,000, ~~which~~each. ~~was~~On the ~~fair~~same ~~market~~day, ~~value~~the Company issued 10,000 shares of ~~the~~its restricted common stock. ~~The~~to ~~shares~~Mark ~~were~~Beloyan, ~~not~~a ~~registered~~principal ~~under~~of ~~the~~Tradespot ~~Securities~~Markets ~~Act~~and Admiral Investment Banking, pursuant to the exercise of a warrant at an exercise price of $0.01 per share. The shares were sold in reliance ~~upon~~on the exemption ~~from~~in ~~registration provided by~~ Section 4(2) of the Securities Act, ~~which~~of ~~exempts~~1933 for transactions ~~by an issuer~~ not involving any public offering. The certificates representing the shares ~~received~~bear a restricted legend~~. The~~, ~~agreement~~and ~~was~~the ~~later~~persons ~~rescinded~~acquiring ~~and~~ the shares ofrepresented ~~common~~that ~~stock~~they ~~were~~acquired ~~returned~~the onshares ~~December~~with ~~30,~~investment ~~2019 and cancelled~~intent.

34. During the three months ended June 30, 2021, the Company sold a total of 60,002 shares of its common stock, at $1.50 per share, to four accredited investors for a total of $90,000. In addition, during the same three months ended June 30, 2021, the Company raised $50,000 through the sale of one of its Series 2 Senior Convertible Promissory Note (“Note”) on May 27, 2021. The Note is for a term of three years and bears interest at a rate at eight Percent (8%) per annum. The Note will automatically convert to Common Stock of the Company if the Company has received $1,000,000 from its offering or any other source or sources at a conversion price of $1.50 per share. The Note can also be voluntarily converted by the holder. A copy of the form of Series 2 Senior Convertible Promissory Note is attached hereto as Exhibit 10.8. The Payee will be issued Warrants for the purchase of common stock in the Company with a value equal to fifty percent (50%) of the face amount of the Note and effective as of the date of any Conversion to shares of common stock in the Company. Such Warrants shall be priced at $1.50 per share during the three-year term of the Note or any extension of the Note. The shares, Note and Warrants were issued in reliance on the exemption in Section 4(2) of the Securities Act of 1933 for transactions not involving any public offering. The certificates representing the shares bear a restricted legend, and the persons acquiring the shares represented that they acquired the shares with investment intent.

In5. During the three ~~month~~months ~~period~~ ended ~~September~~December 3031, ~~2020~~2021, wethe ~~sold~~Company 73issued an aggregate of 75,~~333~~000 shares of ~~our~~its restricted common stock to afive ~~total~~persons ofat ~~three~~a ~~investors~~price ~~for total proceeds~~ of $~~110,001~~1.50 Inper ~~the~~share. ~~three~~A ~~months~~total ~~ended~~of ~~December 31~~35,000 ~~2020~~of wethese ~~sold 33,334~~ shares ofwere ~~our~~issued ~~restricted common stock~~ to ~~one~~satisfy ~~investor~~$52,500 ~~for~~of ~~total~~the ~~proceeds~~Company’s ofaccounts ~~$50,000~~payable. The shares were sold in reliance on the exemption in Section 4(2) of the Securities Act of 1933 for transactions not involving any public offering. The certificates representing the shares bear a restricted legend, and the persons acquiring the shares represented that they acquired the shares with investment intent.

146. On February 10, 2022 Company issued 33,334 shares of restricted common stock priced at $1.50 per share. The shares were sold in reliance on the exemption in Section 4(2) of the Securities Act of 1933 for transactions not involving any public offering. The certificates representing the shares bear a restricted legend, and the persons acquiring the shares represented that they acquired the shares with investment intent.

7. On February 16, 2022, the Company sold of $100,000 of Notes pursuant to its Secured Note Private Placement Memorandum dated October 1, 2020. The Notes were sold in reliance on the exemption in Section 4(2) of the Securities Act of 1933 for transactions not involving any public offering.

In the three months ended December 31, 2020, we sold three Series 2 Senior Convertible Secured Promissory Notes in the respective amounts of $10,000 (on October 23, 2020), $10,000 (on October 23, 2020) and $30,000 (on November 2, 2020) to three investors. A form of the Series 2 Senior Convertible Secured Promissory Note is attached hereto as Exhibit 10.09. The Notes bear interest at 8.0% per annum, have a three year term, and the Maturity Dates are automatically extended for successive six month periods in the event the Company has not raised gross proceeds from its October 1, 2020 private offering or financing from any other source or sources of at least $1,000,000. Each Note is secured on a pro rata basis with the other Notes by the assets of the Company. Each Note is automatically converted into shares of our common stock at a price of $1.50 per share once we have generated gross proceeds of $1,000,000 from the October 1, 2020 private offering or financing from any other source or sources. The holders of the Notes may also voluntarily convert the balances owed under the Notes at an earlier time at the same conversion price of $1.50 per share. Each Note holder will also be issued warrants to purchase shares of our restricted common stock at $1.50 per share at the time of conversion in an amount equal to 50% of the face amount of the Note, which are exercisable for a period of three years.

On February 26, 2021, the Company issued 10,000 shares of its restricted common stock to its Vice President Jeffrey M. Pogol, and 10,000 shares of its restricted common stock to another service provider, for services rendered which were valued at $2,000 each. On the same day, the Company issued 10,000 shares of its restricted common stock to Mark Beloyan, a principal of Tradespot Markets and Admiral Investment Banking, pursuant to the exercise of a warrant at an exercise price of $0.01 per share. The shares were sold in reliance on the exemption in Section 4(2) of the Securities Act of 1933 for transactions not involving any public offering. The certificates representing the shares bear a restricted legend, and the persons acquiring the shares represented that they acquired the shares with investment intent.

Use of Proceeds of Registered Securities

There were no proceeds received during the calendar year ended December 31, ~~2020~~2021, from the sale of registered securities.

Purchases of Equity Securities by Us and Affiliated Purchasers

Except as described above under the heading “Recent Sales of Unregistered Securities; Use of Proceeds from Registered Securities,” during the last three fiscal years, there were no purchases of any equity securities of ours by us or any person on our behalf; nor were there any purchases of our equity securities by any affiliate of ours during the last three fiscal years.

ITEM 6: ~~SELECTED~~ ~~FINANCIAL DATA~~[RESERVED]

~~Not required for smaller reporting companies.~~18

ITEM 7: MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward-looking Statements

Statements made in this Annual Report, which are not purely historical, are forward-looking statements with respect to the goals, plan objectives, intentions, expectations, financial condition, results of operations, future performance and our business, including, without limitation, (i) our ability to raise capital, and (ii) statements preceded by, followed by or that include the words “may,” “would,” “could,” “should,” “expects,” “projects,” “anticipates,” “believes,” “estimates,” “plans,” “intends,” “targets” or similar expressions.

Forward-looking statements involve inherent risks and uncertainties, and important factors (many of which are beyond our control) that could cause actual results to differ materially from those set forth in the forward-looking statements, including the following, general economic or industry conditions, nationally and/or in the communities in which we may conduct business, changes in the interest rate environment, legislation or regulatory requirements, conditions of the securities markets, our ability to raise capital, changes in accounting principles, policies or guidelines, financial or political instability, acts of war or terrorism, other economic, competitive, governmental, regulatory and technical factors affecting our current or potential business and related matters.

Accordingly, results actually achieved may differ materially from expected results in these statements. Forward-looking statements speak only as of the date they are made. We do not undertake, and specifically disclaim, any obligation to update any forward-looking statements to reflect events or circumstances occurring after the date of such statements.

Plan of Operation

Our plan of operation for the next 12 months is to: (i) market the licensing of the Company’s technology in states in the U.S. where ~~cannabis~~marijuana and/or hemp has been legalized both for medicinal and/or recreational use, and in the Canadian provinces; ~~and~~ (ii) seek to raise additional equity funding so that the Company may pursue the construction and operation of a facility to produce and market hemp cigarettes to be located in Northern Nevada; and (iii) complete the transactions which are the subjects of the two letters of intent signed by the Company which include acquiring an Oregon company which specializes in hemp-related products and forming a joint venture to produce, market and distribute hemp cigarettes and hemp-based products in the United States, Canada and Mexico using the Company’s Patented and Patent Pending Technologies. During the next 12 months, our cash requirements include expenses to market our technology; expenses to construct and operate a facility to produce and market hemp cigarettes to be located in Northern Nevada; the payment of our SEC reporting and filing expenses, including associated legal and accounting fees; and costs incident to maintaining our good standing as a corporation in our state of organization. We anticipate that we will need to raise additional equity funds to successfully commence and operate a facility to produce and market hemp cigarettes. We We have no commitments to raise any additional funds at the present time, and we can offer no assurance that we will be able to raise additional funds on terms acceptable to the Company.

Liquidity and Capital Resources

WeAs of December 31, 2021, we had total current assets of $4158,~~770~~062 consisting ~~entirely~~ of $55,351 in cash and $~~469~~2,~~893~~711 in a deposit. We had $484,672 in total current liabilities as of December 31, ~~2020~~ 2021. Our total current liabilities of $~~469~~484,~~893~~672 consisted of notes payable $375,500, notes payable-related party of $2313,306, accounts payable and accrued expenses of $5888,~~373~~500 and accounts payable and accrued expenses-Related party of $127,~~714~~366. See our Plan of Operation above for information about our cash requirements for the next 12 months.

The Company also has $~~125~~90,~~695~~345 in property, plant and equipment, net, and $50100,000 in long term liabilities which are in convertible notes payable. ~~All of the $50,000 in long term liabilities are convertible.~~

For a description of the various loans that the Company ~~has~~ received during the year ended December 31, ~~2020~~2021, and subsequent to December 31, ~~2020~~2021, see footnotes 54, 65 and 87 to the Company’s financial statements included herein. The Company intends to repay these loans from selling the Company’s hemp farming equipment and from raising ~~additional capital. The Company can offer no assurance that it will be successful in its efforts to raise additional capital.~~

See the Exhibit Index below to determine where copies of the various promissory notes are located. The Company may seek additional loans from third parties on the same or similar terms in the near future on an as needed basis, but the Company can offer no assurance that additional funds will be available to the Company.19

additional capital. The Company can offer no assurance that it will be successful in its efforts to raise additional capital.

See the Exhibit Index below to determine where copies of the various promissory notes and/or amendments are located. The Company may seek additional loans from third parties on the same or similar terms in the near future on an as needed basis, but the Company can offer no assurance that additional funds will be available to the Company.

Results of Operations

Year Ended December 31, ~~2020~~2021 Compared Year Ended December 31, ~~2019~~2020

We had no revenues during the year ended December 31, ~~2020~~2021. We hope to start earning revenues during the present fiscal year ending December 31, ~~2021~~2022.

We incurred general and administrative expenses of $~~222~~220,~~561~~576 for the year ended December 31, ~~2020~~2021, ana ~~increase~~decrease of $221,~~531~~985 ~~over~~from the $~~200~~222,~~030~~561 of general and administrative expenses incurred during the year ended December 31, ~~2019~~2020. We incurred depreciation of $35,350 in the year ended December 31, ~~2020~~2021 aswhich ~~compared~~is tothe ~~$15,705~~same as ~~incurred in~~ the ~~year ended December 31, 2019. We sustained a crop loss of~~ $~~246~~35,~~914~~350 inincurred ~~the year ended December 31, 2019 due to the poor quality of the seeds that were purchased. We had no crop loss expense~~ in the year ended December 31, 2020.

We incurred interest expense of $4258,~~955~~359 in the year ended December 31, ~~2020~~2021, an increase of $2915,~~926~~404 from the $1342,~~029~~955 of interest expense incurred in the year ended December 31, ~~2019~~2020. The increase is due to the increase in aggregate principal balance of the ~~Notes~~Convertible ~~Payable~~notes payable in the later period from increased borrowings, and increases in interest rates in some of the Notes Payable in the later period. We also incurred interest expense - related party of $42,~~645~~152 in the year ended December 31, ~~2020~~2021, ana ~~increase~~decrease of $42,~~076~~493 from the $~~569~~4,645 of interest expense - related party incurred in the year ended December 31, ~~2019~~2020. The ~~increase~~decrease is due to the ~~increase~~Company’s inrepayment ~~aggregate principal balance~~ of ~~the Notes Payable-Related Party in the later period from increased borrowings~~$10,000 ~~and~~of ~~increases~~principal inbalance ~~interest rates in some~~ of the Notes Payable-Related Party in the later period.

We incurred a net loss of $~~305~~316,~~511~~437, or approximately $0.02 per share, in the year ended December 31, ~~2020~~2021, which is $~~170~~10,~~736~~926 ~~less~~more than the net loss of $~~476~~305,~~247~~511 incurred in the year ended December 31, ~~2019~~2020. The ~~decrease~~increase in the net loss incurred in the later period is largely attributable to ~~the~~an ~~reduction~~increase ~~of $246,914~~ in ~~crop loss in the later period, partially offset by increases of $22,531 in general and administrative expenses and increases in~~ interest expense, ~~interest expense-related party and depreciation~~ incurred in the later period.

Capital Resources

The cash flows from operating activities during the year ended December 31, ~~2020~~2021 consisted of the following: The net loss of $~~305~~316,~~511~~437 partially offset by $35,350 in depreciation, $7482,500 in ~~warrant~~issuance ~~expense~~of common stock for services, a $1230,~~145~~127 increase in accounts payable and accrued expenses ~~– related party~~, and a decrease of $45,~~171~~348 in accounts payable and accrued expenses – Related party, and a $2,711 increase in deposit, resulting in net cash used in operating activities of $~~187~~176,~~687~~519.

The cash flows from operating activities during the prior year ended December 31, ~~2019~~2020 consisted of the following: The net loss of $~~476~~305,~~247~~511 partially offset by $1535,~~705~~350 in depreciation, $74,500 as warrant expense, an increase of $3712,~~120~~145 in accounts payable and accrued expenses – Related Party, and ana ~~increase~~decrease of $~~569~~ 4,171 in accounts payable and accrued expenses ~~– related party~~, resulting in net cash used in operating activities of $~~422~~187,~~853~~687.

WeThe ~~had no net~~ cash ~~used~~flows infrom ~~investing~~financing activities in during the year ended December 31, ~~2020,~~2021 asconsisted ~~compared~~of tothe ~~$176,750~~following: ~~net~~We ~~cash~~received ~~used~~proceeds infrom ~~the~~exercise ~~year~~of ~~ended~~warrants ~~December~~of 31$100, ~~2019~~proceeds from the sale ~~purchase~~of common stock of ~~property~~$150,000, ~~plant~~proceeds from convertible notes payable of $50,000, and ~~equipment~~repayments on notes payable – related parties of $10,000, resulting in net cash provided by financing activities of $190,100.

The cash flows from financing activities during the year ended December 31, 2020 consisted of the following: We received cash proceeds from the sale of common stock of $160,001, proceeds from notes payable of $25,500, proceeds from convertible notes payable of $50,000, proceeds from notes payable – related ~~party~~ parties of $18,749, and repayments on notes payable – related parties of $30,000, resulting in net cash provided by financing activities of $224,250.

The cash flows from financing activities during the year ended December 31, 2019 consisted of the following: We received cash proceeds from notes payable of $350,000 and cash proceeds from notes payable – related parties of $34,577, resulting in net cash provided by financing activities of $384,557.20

Going Concern

The Company’s financial statements have been presented on the basis that it is a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has sustained operating losses during the current year-to-date and may not achieve the level of profitable operations to sustain its activities. These factors raise substantial doubt as to its ability to obtain debt and/or equity financing and achieve profitable operations.

Management intends to raise additional operating funds to fund operations for the next 12 months through proceeds to be received from the planned sale of our hemp farming equipment, and through raising funds through equity and/or debt offerings. However, there can be no assurance management will be successful in its endeavors. Ultimately, the Company will need to achieve profitable operations in order to continue as a going concern.

There are no assurances that the Company will be able to either (1) achieve a level of revenues adequate to generate sufficient cash flow from operations; or (2) obtain additional financing through either private placement, public offerings and/or bank financing necessary to support its working capital requirements. To the extent that funds generated from operations and any private placements, public offerings and/or bank financing are insufficient, the Company will have to raise additional working capital. No assurance can be given that additional financing will be available, or if available, will be on terms acceptable to the Company. If adequate working capital is not available to the Company it may be required to curtail its operations.

Emerging Growth Company Critical Accounting Policy Disclosure

The Company qualifies as an “emerging growth company” under the 2012 JOBS Act. Section 107 of the JOBS Act provides that an emerging growth company can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. As an emerging grown company, the Company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. The Company may elect to take advantage of the benefits of this extended transition period in the future.

Off-Balance Sheet Arrangements

We had no off-balance sheet arrangements of any kind for the year ended December 31, ~~2020~~2021.

ITEM 7A: QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not required for smaller reporting companies.

1721

ITEM 8: FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

HIGH SIERRA TECHNOLOGIES, INC.

AND SUBSIDIARIES

AUDITED CONSOLIDATED FINANCIAL STATEMENTS

For the Years Ended December 31, ~~2020~~2021 and December 31, ~~2019~~ 2020

1822

HIGH SIERRA TECHNOLOGIES, INC.

CONTENTS

	PAGE
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM	2024
CONSOLIDATED BALANCE SHEETS	2125
CONSOLIDATED STATEMENTS OF OPERATIONS	2226
CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’ (DEFICIT)	2327
CONSOLIDATED STATEMENTS OF CASH FLOWS	2428
NOTES TO AUDITED CONSOLIDATED FINANCIAL STATEMENTS	2529

1923

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (PCAOB ID: 6117)

To the Board of Directors and Stockholders

High Sierra Technologies, Inc.

Reno, Nevada

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheets of High Sierra Technologies, Inc. (the Company) as of December 31, ~~2020~~2021 and ~~2019~~2020, and the related statements of operations, stockholders’ deficit, and cash flows for the years then ended, and the related notes (collectively referred to as the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as December 31, ~~2020~~2021 and ~~2019~~2020, and the results of its operations and its cash flows for the years then ended, in conformity with accounting principles generally accepted in the United States of America.

Consideration of the Company’s Ability to Continue as a Going Concern

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company has suffered recurring losses and has minimal operations which raise substantial doubt about its ability to continue as a going concern. Management’s plans in regard to these matters are described in Note 2. The consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Basis for Opinion

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

/s/ Pinnacle Accountancy Group of Utah

We have served as the Company’s auditor since 2015.

Pinnacle Accountancy Group of Utah

(a dba of Heaton & Company, PLLC)

Farmington, Utah

~~April~~March 1421, ~~2020~~2022

2024

HIGH SIERRA TECHNOLOGIES, INC.
Consolidated Balance Sheets
December 31, 2020 and 2019
			December 31,
			2020	2019
ASSETS
	Current Assets
		Cash	$ 41,770	$ 5,207
		Total Current Assets	41,770	5,207
	Property, Plant and Equipment, net		125,695	161,045
		Total Assets	$ 167,465	$ 166,252
LIABILITIES AND STOCKHOLDERS' (DEFICIT)
	Current Liabilities
		Notes payable	$ 375,500	$ 350,000
		Notes payable-Related party	23,306	34,557
		Accounts payable and accrued expenses	58,373	62,544
		Accounts payable and accrued expenses-Related party	12,714	569
		Total Current Liabilities	469,893	447,670
	Long Term Liabilities
		Convertible notes payable	50,000	-
		Total Liabilities	519,893	447,670
	Commitments and contingencies		-	-
	Stockholders’ (Deficit)
		Preferred stock, no par value, non-voting, 5,000,000 shares
		authorized, 0 shares issued and outstanding	-	-
		Common stock, no par value, 50,000,000 shares authorized;
		20,296,309 and 20,189,642 issued and outstanding at
		December 31, 2020 and 2019	471,849	237,348
		Accumulated (Deficit)	(824,277)	(518,766)
		Total Stockholders' (Deficit)	(352,428)	(281,418)
		Total Liabilities and Stockholders' (Deficit)	$ 167,465	$ 166,252

HIGH SIERRA TECHNOLOGIES, INC.

Consolidated Balance Sheets

December 31, 2021 and 2020

	December 31,
		2021		2020
ASSETS

Current Assets
Cash	$	55,351	$	41,770

Deposit		2,711		-

Total Current Assets		58,062		41,770

Property, Plant and Equipment, net		90,345		125,695

Total Assets	$	148,407	$	167,465

LIABILITIES AND STOCKHOLDERS' (DEFICIT)

Current Liabilities
Notes payable	$	375,500	$	375,500
Notes payable-Related party		13,306		23,306
Accounts payable and accrued expenses		88,500		58,373
Accounts payable and accrued expenses-Related party		7,366		12,714

Total Current Liabilities		484,672		469,893

Long Term Liabilities
Convertible notes payable		100,000		50,000

Total Liabilities		584,672		519,893

Commitments and contingencies		-		-

Stockholders (Deficit)
Preferred stock, no par value, non-voting, 5,000,000 shares authorized, 0 shares issued and outstanding		-		-
Common stock, no par value, 50,000,000 shares authorized; 20,461,311 and 20,296,309 shares issued and outstanding at December 31, 2021 and 2020		704,449		471,849
Accumulated (Deficit)		(1,140,714)		(824,277)
Total Stockholders' (Deficit)		(436,265)		(352,428)

Total Liabilities and Stockholders' (Deficit)	$	148,407	$	167,465

The accompanying footnotes are an integral part of these consolidated financial statements.

2125

HIGH SIERRA TECHNOLOGIES, INC.

Consolidated Statements of Operations

		Years Ended
		December 31,
		2020	2019
Revenues		$ -	$ -
	Total revenues	-	-
Operating Expenses
	Depreciation	35,350	15,705
	Crop loss	-	246,914
	General and administrative	222,561	200,030
	Total operating expenses	257,911	462,649
(Loss) from operations		(257,911)	(462,649)
Other (expense)
	Interest (expense)	(42,955)	(13,029)
	Interest (expense)-Related party	(4,645)	(569)
	Total other (expense)	(47,600)	(13,598)
(Loss) before income taxes		(305,511)	(476,247)
	Income taxes	-	-
Net (loss)		$ (305,511)	$ (476,247)
(Loss) per share-Basic and diluted		$ (0.02)	$ (0.02)
Weighted average shares outstanding-
	Basic and diluted	20,215,453	20,309,094

For the Years Ended December 31, 2021 and 2020

	Years Ended December 31,
		2021		2020

Revenues	$	-	$	-

Operating Expenses
Depreciation		35,350		35,350
General and administrative		220,576		222,561

Total operating expenses		255,926		257,911

(Loss) from operations		(255,926)		(257,911)

Other (expense)
Interest (expense)		(58,359)		(42,955)
Interest (expense)-Related party		(2,152)		(4,645)

Total other (expense)		(60,511)		(47,600)

(Loss) before income taxes		(316,437)		(305,511)
Income taxes		-		-

Net (loss)	$	(316,437)	$	(305,511)

(Loss) per share-Basic and diluted	$	(0.02)	$	(0.02)

Weighted average shares outstanding:
Basic and diluted		20,369,497		20,215,453

The accompanying footnotes are an integral part of these consolidated financial statements.

2226

HIGH SIERRA TECHNOLOGIES, INC.
Consolidated Statements of Stockholders' (Deficit)
For the Years Ended December 31, 2020 and 2019
	Preferred Stock		Common Stock		Accumulated	Stockholders'
	Shares	Amount	Shares	Amount	(Deficit)	(Deficit)
Balance-January 1, 2019	-	$ -	20,189,642	$ 237,348	$ (42,519)	$ 194,829
Net (loss) for the year ended December 31, 2019	-	-	-	-	(476,247)	(476,247)
Balance-December 31, 2019	-	-	20,189,642	237,348	(518,766)	(281,418)
Common stock issued for cash	-	-	106,667	160,001	-	160,001
Warrants issued for consulting expenses	-	-	-	74,500	-	74,500
Net (loss) for the year ended December 31, 2020	-	-	-	-	(305,511)	(305,511)
Balance-December 31, 2020	-	$ -	20,296,309	$ 471,849	$ (824,277)	$ (352,428)

HIGH SIERRA TECHNOLOGIES, INC.

Consolidated Statements of Stockholders' (Deficit)

For the Years Ended December 31, 2021 and 2020

	Preferred Stock			Common Stock				Accumulated			Stockholders'
	Shares		Amount	Shares		Amount		(Deficit)			(Deficit)
Balance-January 1, 2020	-	$	-	20,189,642	$	237,348	$	(518,766	)	$	(281,418	)

Proceeds from sale of common stock	-		-	106,667		160,001		-			160,001

Warrants issued for consulting expenses	-		-	-		74,500		-			74,500

Net (loss) for the year ended December 31, 2020	-		-	-		-		(305,511	)		(305,511	)

Balance-December 31, 2020	-		-	20,296,309		471,849		(824,277	)		(352,428	)

Common stock issued for services	-		-	55,000		82,500		-			82,500

Proceeds from exercise of warrants	-		-	10,000		100		-			100

Proceeds from the sale of common stock	-		-	100,002		150,000		-			150,000

Net (loss) for the year ended December 31, 2021	-		-	-		-		(316,437	)		(316,437	)

Balance-December 31, 2021	-	$	-	20,461,311	$	704,449	$	(1,140,714	)	$	(436,265	)

The accompanying footnotes are an integral part of these consolidated financial statements.

HIGH SIERRA TECHNOLOGIES, INC.
Consolidated Statements of Cash Flows
	Years Ended
	December 31,
	2020	2019
CASH FLOWS FROM OPERATING ACTIVITIES:
Net (loss)	$ (305,511)	$ (476,247)
Adjustments to reconcile net loss to net cash used
in operating activities:
Depreciation	35,350	15,705
Warrants issued for consulting expenses	74,500	-
Changes in operating assets and liabilities:
Increase (decrease) in accounts payable and accrued expenses	(4,171)	37,120
Increase in accounts payable and accrued expenses-Related party	12,145	569
Net cash used in operating activities	(187,687)	(422,853)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property, plant and equipment	-	(176,750)
Net cash used in investing activities	-	(176,750)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from sale of common stock	160,001	-
Proceeds from notes payable	25,500	350,000
Proceeds from convertible notes payable	50,000
Proceeds from notes payable – related party	18,749	34,557
Repayments on notes payable-related party	(30,000)	-
Net cash provided by financing activities	224,250	384,557
Net increase (decrease) in cash	36,563	(215,046)
CASH AT BEGINNING OF PERIOD	5,207	220,253
CASH AT END OF PERIOD	$ 41,770	$ 5,207
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for interest	$ 14,500	$ 2,250
Cash paid for income taxes	$ -	$ -

The accompanying footnotes are an integral part of these consolidated financial statements.

HIGH SIERRA TECHNOLOGIES, INC.

~~Notes~~Consolidated toStatements ~~Consolidated~~of ~~Financial~~Cash ~~Statements~~Flows

For the Years Ended December 31, ~~2020~~2021 and ~~2019~~2020

NOTE 1- Summary of History and Significant Accounting Policies

	Year Ended December 31,
		2021		2020

CASH FLOWS FROM OPERATING ACTIVITIES:
Net (loss)	$	(316,437)	$	(305,511)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation		35,350		35,350
Issuance of warrants for consulting expenses		-		74,500
Issuance of common stock for services		82,500		-
Changes in assets and liabilities:
(Increase) in deposit		(2,711)		-
Increase (decrease) in accounts payable and accrued expenses		30,127		(4,171)
(Decrease) increase in accounts payable and accrued expenses-Related party		(5,348)		12,145

Net cash (used) in operating activities		(176,519)		(187,687)

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from exercise of warrants		100		-
Proceeds from sale of common stock		150,000		160,001
Proceeds from notes payable		-		25,500
Proceeds from convertible notes payable		50,000		50,000
Proceeds from notes payable-Related party		-		18,749
Payments on notes payable-Related party		(10,000)		(30,000)

Net cash provided by financing activities		190,100		224,250

Net increase in cash		13,581		36,563

CASH AT BEGINNING PERIOD		41,770		5,207

CASH AT END OF PERIOD	$	55,351	$	41,770

SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for interest	$	25,270	$	14,500
Cash paid for income taxes	$	-	$	-

The accompanying footnotes are an integral part of these consolidated financial statements.

HIGH SIERRA TECHNOLOGIES, INC.

Notes to Consolidated Financial Statements

December 31, 2021 and 2020

NOTE 1 – Summary of History and Significant Accounting Policies

Nature of Operations

Gulf & Orient Steamship Company, LTD. (“Gulf” or the “Company”) was incorporated in the State of Colorado on May 9, 1996. Gulf originally intended to engage in the business of marine transportation.

On December 31, 2018, Gulf entered into a Share Exchange Agreement with High Sierra Technologies, Inc., a Nevada corporation (“High Sierra”), and all of its shareholders. The shareholders of High Sierra were issued shares of the Gulf’s common stock on a one for one share basis in exchange for their shares of High Sierra’s common stock. High Sierra became a wholly-owned subsidiary of Gulf in the business combination. The Share Exchange was treated as a reverse merger and recapitalization, and as a result, the consolidated financial statements are presented under successor entity reporting, with an inception date of August 6, 2018. Subsequently Gulf’s name was changed to High Sierra Technologies, Inc.

High Sierra Technologies, Inc., the wholly-owned subsidiary, was incorporated in the State of Nevada on August 6, 2018. It was formed with the intention that it would become the assignee, owner and licensor of certain Intellectual Property (the “Intellectual Property”) that was, prior to assignment, the property of Vincent C. Lombardi, Ph.D., who is an officer, director and co-founder of the subsidiary. The subsidiary was further formed with the goal that it would continue to develop and expand its intellectual property portfolio with an emphasis on the recreational cannabis industry as well as the industrial hemp industry.

Through its subsidiary, the Company is a start-up that develops patents and other products used in the processing of cannabis, including industrial hemp, and will license these technologies to companies in the industry. The Company will likely incur research and development expenses in the future and intends to develop a policy regarding the same. ~~The Company was growing industrial hemp on a 200-acre property it leased in McDermitt, Nevada and incurred expenses in relation to this project and the failure of the crop during 2019 (see Note 3).~~

Basis of Presentation and Consolidation

The accompanying consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America.

The Company consolidates its subsidiaries in accordance with ASC 810, and specifically ASC 810-10-15-8 which states, "[t]he usual condition for a controlling financial interest is ownership of a majority voting interest, and, therefore, as a general rule ownership by one reporting entity, directly or indirectly, or over 50% of the outstanding voting shares of another entity is a condition pointing toward consolidation." All inter-company transactions have been eliminated during consolidation.

Concentration of Risk

The Company places its cash and temporary cash investments with established financial institutions. At times, such cash and investments may be in excess of the FDIC insurance limit.

2529

HIGH SIERRA TECHNOLOGIES, INC. Notes to Consolidated Financial Statements December 31, 2021 and 2020

Notes to Consolidated Financial Statements

December 31, 2020 and 2019

Cash and Cash Equivalents

The Company considers all highly liquid investments purchased with original maturities of three months or less to be cash equivalents.

Stock-based Compensation

The Company records stock-based compensation in accordance with ASC 718, Compensation - Stock ~~Based~~ Compensation, which requires the measurement and recognition of compensation expense based on grant date fair values for all share-based awards made to third parties, employees and directors, including stock options. ~~Effective January 1, 2019, the Company adopted ASU 2018-07, Compensation – Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting.~~

ASC 718 requires companies to estimate the fair value of share-based awards to employees and directors on the date of grant ~~using an option-pricing model~~. The Company uses the Black-Scholes option-pricing model as its method of determining fair value. This model is affected by the Company's stock price as well as assumptions regarding a number of subjective variables. These subjective variables include but are not limited to the Company's expected stock price volatility over the term of the awards, and actual and projected employee stock option exercise behaviors. The value of the portion of the award that is ultimately expected to vest is recognized as an expense in the statement of operations over the requisite service period.

Upon the adoption of ASU 2018-07, the Company measures the fair value of equity instruments for non-employee payment awards on the grant date.

Investment in Growing Crops

The Company’s Investment in Growing Crops represented the total cost of the crop inputs in the ground. These were recorded at cost and were to be expensed to cost of goods sold once the crops were harvested and sold.

The crop harvest failed and the Company incurred a $246,914 loss from the preparation, planting and harvesting of the crop during 2019.

Long-lived Assets

Long-lived assets are stated at cost. Maintenance and repairs are expensed as incurred. Depreciation is determined using the straight-line method over the estimated useful lives of the assets, which is five years.

Where an impairment of a property’s value is determined to be other than temporary, impairment for the estimated potential loss is recorded to adjust the property to its net realizable value.

When items of building or equipment are sold or retired, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is included in the results of operations. The Company does not have any long-lived tangible assets, which are considered impaired as of December 31, ~~2020~~2021 and ~~2019~~2020.

The Company applies the provisions of ASC 360~~-10~~, Property, Plant and Equipment, where applicable to all long-lived assets. ASC 360~~-10~~ addresses accounting and reporting for impairment and disposal of long-lived assets. The Company periodically evaluates the carrying value of long-lived assets to be held and used in accordance with ASC 360~~-10~~. ASC 360~~-10~~ requires impairment losses to be recorded on long-lived assets used in operations when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those assets are less than the assets’ carrying amounts. In that event, a loss is recognized based on the amount by which the carrying amount exceeds the fair market value of the long-lived assets. Loss on long-lived assets to be disposed of is determined in a similar manner, except that fair market values are reduced for the cost of disposal.

2630

HIGH SIERRA TECHNOLOGIES, INC. Notes to Consolidated Financial Statements December 31, 2021 and 2020

Notes to Consolidated Financial Statements

December 31, 2020 and 2019

Intangible Assets

Goodwill and intangible assets are reviewed for potential impairment in accordance with ASC 350, Intangibles - Goodwill and Other, whenever events or circumstances indicate that their carrying amounts may not be recoverable. The Company had no such intangibles at December 31, ~~2020~~2021 and ~~2019~~2020, and recorded no impairment losses during the years ended December 31, ~~2020~~2021 and ~~2019~~2020. The Company currently writes off all costs related to any intangible assets it has or is acquiring to current operating expenses.

Revenue Recognition

The Company applies ASC 606, Revenue from Contracts with Customers. Under ASC 606, the Company will recognize revenue from the commercial sales of products, licensing agreements and contracts to perform pilot studies by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue as each performance obligation is satisfied.

Advertising

Advertising costs are expensed as incurred. Advertising expenses for the years ended December 31, ~~2020~~2021 and ~~2019~~2020 were $0.

Fair Value of Financial Instruments

The Company adopted ASC 820, Fair Value Measurements and Disclosures, which provides a framework for measuring fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The standard also expands disclosures about instruments measured at fair value and establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:

Level 1 — Quoted prices for identical assets and liabilities in active markets;

Level 2 — Quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and

Level 3 — Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Management makes these estimates using the best information available at the time the estimates are made; however actual results could differ materially from those estimates.

2731

HIGH SIERRA TECHNOLOGIES, INC. Notes to Consolidated Financial Statements December 31, 2021 and 2020

Notes to Consolidated Financial Statements

December 31, 2020 and 2019

Emerging Growth Company Critical Accounting Policy Disclosure

The Company qualifies as an “emerging growth company” under the 2012 JOBS Act. Section 107 of the JOBS Act provides that an emerging growth company can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. As an emerging grown company, the Company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. The Company has chosen to “opt out” of such extended transition period, and as a result, the Company will comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies.

Income Taxes

The Company accounts for income taxes under ASC 740~~-10-30~~, Income Taxes. Deferred income tax assets and liabilities are determined based upon differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the statements of operations in the period that includes the enactment date.

The Company ~~adopted~~follows ASC 740-10-25, which addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the financial statements. Under ASC 740-10-25, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent (50%) likelihood of being realized upon ultimate settlement. ASC 740-10-25 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. The Company had no material adjustments to its liabilities for unrecognized income tax benefits according to the provisions of ASC 740-10-25.

Loss Per Share

Net loss per common share is computed pursuant to ASC 260~~-10-45~~, Earnings Per Share. Basic net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. Diluted net loss per share is computed by dividing net loss by the weighted average number of shares of common stock and potentially outstanding shares of common stock during each period, unless their effect is anti-dilutive due to continuing losses. As of December 31, ~~2020~~2021, the Company had a total of 83106,~~333~~666 (5040,000 from outstanding warrants and 3366,~~333~~666 from convertible notes payable) potentially dilutive shares outstanding. As of December 31, ~~2019~~2020, there were no potentially dilutive shares outstanding.

Recent Accounting Pronouncements

We do not expect the adoption of recently issued accounting pronouncements to have a significant impact on our results of operations or financial position.

2832

HIGH SIERRA TECHNOLOGIES, INC. Notes to Consolidated Financial Statements December 31, 2021 and 2020

Notes to Consolidated Financial Statements

December 31, 2020 and 2019

NOTE 2 – Financial Condition and Going Concern

The Company’s financial statements have been presented on the basis that it is a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has sustained operating losses during the current year and may not achieve the level of profitable operations to sustain its activities. These factors raise substantial doubt as to its ability to obtain debt and/or equity financing and achieve profitable operations.

Management intends to raise additional operating funds through equity and/or debt offerings. However, there can be no assurance management will be successful in its endeavors. Ultimately, the Company will need to achieve profitable operations in order to continue as a going concern.

NOTE 3 – ~~Investment~~Property inand ~~Growing Crops~~Equipment

~~Investment~~ inAt ~~growing crops consisted of the cost of the crop inputs in the ground at~~ December 31, ~~2019~~2021 and ~~were~~2020, ~~recorded~~property ~~at cost~~ and ~~were~~equipment ~~expensed~~consisted ~~to Crop Loss on the statement~~ of ~~operations during~~ the ~~fourth~~following: quarter of 2019 since the crop harvest and related farming activities failed. The Company incurred a loss from the crop activities in the amount of $246,914 during 2019. The Company is continuing to pursue opportunities in the recreational and industrial cannabis industries, but is not currently engaging in the growing of crops.

NOTE 4 – Property and Equipment

	Useful	December 31,		December 31,
	Lives	2021		2020

Equipment	5	$	176,750	$	176,750
Less: accumulated depreciation			(86,405)		(51,055)
		$	90,345	$	125,695

AtDepreciation ~~December~~expense 31was $35,350 ~~2020~~for ~~and~~the ~~2019,~~years ~~property~~ended ~~and~~December ~~equipment~~31, ~~consisted~~2021 ofand ~~the~~2020. ~~following:~~

	Useful Lives	December 31, 2020	December31, 2019
Equipment	5	$ 176,750	$ 176,750
Less: accumulated depreciation		(51,055)	(15,705)
		$ 125,695	$ 161,045

~~Depreciation~~HIGH ~~expense~~SIERRA ~~was $35~~TECHNOLOGIES,~~350~~ ~~and~~INC. ~~$15,702~~Notes ~~for~~to ~~the~~Consolidated ~~years~~Financial ~~ended~~Statements December 31, ~~2020~~2021 and ~~2019, respectively.~~ 2020

29 NOTE 4 – Notes Payable

HIGH SIERRA TECHNOLOGIES, INC.

Notes to Consolidated Financial Statements

December 31, 2020 and 2019

NOTE 5 – Notes Payable

The Company’s debt consists of the following:

	December 31, 2020	December 31, 2019
		December 31,		December 31,
Notes payable, 12-16% interest, interest and principal due June 6, 2021 through August 12, 2021, unsecured(1)(2)	$ 375,500	$ 350,000
		2021		2020
Notes payable-Series 2 Senior Convertible Secured Promissory Notes, 8% interest, interest and principal due October 21, 2023 through November 2, 2023(3)	50,000	-
Notes payable, 12-16% interest, interest and principal due June 6, 2022 through August 12, 2022, unsecured		$	375,500	$	375,500
Total due	425,500	350,000
Notes payable-Series 2 Senior Convertible Secured Promissory Notes, 8% interest, interest and principal due October 21, 2023 through May 27, 2024(1)			100,000		50,000
Current Portion	375,500	350,000
Total due			475,500		425,500
Long-term portion	$ 50,000	$ -
Current Portion			375,500		375,500
Long-term portion		$	100,000	$	50,000

(1) The Series 2 Notes contain certain automatic and voluntary conversion provisions. The Payee shall have the option to voluntarily convert this Note to shares of the common stock of the Company, at any time during the Term of this Note, or any extension of the note. The shares so converted shall be at the price of the securities being currently offered in the Offering, or $1.50. The Payee shall also be issued Warrants for the purchase of common stock in the Company with a value equal to fifty percent (50%) of the face amount of this Note and effective as of the date of any Conversion to shares of common stock in the Company. Such Warrants shall be priced at $1.50 per share during the three-year term of this Note or any extension of this Note.

~~One~~The ~~note~~Company ~~for~~has ~~$50,000~~incurred ~~includes as~~ an ~~additional return on the debt a 3%~~ interest inexpense ~~the~~of ~~Gross~~$58,359 ~~Crop~~and ~~Yield~~$42,955 ~~from~~during the ~~Company’s~~years ~~hemp~~ended ~~crop~~December ~~in McDermitt~~31, NV2021 and 2020. No ~~accrual~~The Company has ~~been~~interest ~~made~~accrued ~~for~~on ~~this~~the ~~interest~~above ~~due~~notes toin ~~failure~~the amount of ~~crop~~$65,074 and no$31,985 ~~proceeds~~at ~~received~~December ~~from~~31, a2021 ~~Gross~~and ~~Crop Yield~~2020. ~~This~~ ~~note~~The ~~was~~Company ~~purchased~~has bypaid ~~another~~$25,270 ~~note~~and ~~holder~~$14,500 ~~and~~of the ~~additional~~accrued ~~return~~interest ~~from~~in athe ~~Gross~~years ~~Crop~~ended ~~Yield~~December ~~was~~31, ~~eliminated~~2021 and 2020.

~~(2)~~ NOTE 5 – Notes Payable-Related Party

All notes that have become due to the date of this report have been extended to a future due date, as per above date ranges.

(3)

The Series 2 Notes contain certain automatic and voluntary conversion provisions. The Payee shall have the option to voluntarily convert this Note to shares of the common stock of the Company, at any time during the Term of this Note, or any extension of the note. The shares so converted shall be at the price of the securities being currently offered in the Offering, or $1.50. The Payee shall also be issued Warrants for the purchase of common stock in the Company with a value equal to fifty percent (50%) of the face amount of this Note and effective as of the date of any Conversion to shares of common stock in the Company. Such Warrants shall be priced at $1.50 per share during the three-year term of this Note or any extension of this Note.

The Company has incurred an interest expense of $42,955 and $13,029 during the years ended December 31, 2020 and 2019. The Company has interest accrued on the above notes in the amount of $31,985 and $29,819 at December 31, 2020 and 2019.

NOTE 6 – Notes Payable-Related Party

The Company’s related party debt consists of the following:

	December 31, 2020	December 31, 2019
		December 31,		December 31,
Notes payable, 12% interest, interest and principal due June 30, 2021, unsecured(1)	$ 23,306	$ 34,557
		2021		2020
Total due	23,306	34,557
Notes payable, 12% interest, interest and principal due December 31, 2022, unsecured		$	13,306	$	23,306
Current Portion	23,306	34,557
Total due			13,306		23,306
Long-term portion	$ -	$ -
Current Portion			13,306		23,306
Long-term portion		$	-	$	-

~~(1)~~34

~~All~~HIGH ~~notes~~SIERRA ~~that~~TECHNOLOGIES, ~~have~~INC. ~~become~~Notes ~~due~~ to ~~the~~Consolidated ~~date~~Financial ofStatements ~~this~~December ~~report~~31, ~~have~~2021 ~~been~~and ~~extended to a future due date as per the date range listed above.~~ 2020

30During the year ended December 31, 2021, the Company paid back $10,000 of the loans with the President of the Company.

~~HIGH~~The ~~SIERRA~~Company ~~TECHNOLOGIES~~has incurred an interest expense of $2,152 ~~INC~~and $4,645 during the years ended December 31, 2021 and 2020, respectively. The Company has interest accrued on the above notes in the amount of $7,366 and $12,714 at December 31, 2021 and 2020.

~~Notes~~ toNOTE ~~Consolidated~~6 ~~Financial~~– ~~Statements~~Income Taxes

~~December~~The 31Company follows the provisions of ASC 740-10, ~~2020~~which requires a company to determine whether it is more likely than not that a tax position will be sustained upon examination based upon the technical merits of the position. If the more-likely-than-not threshold is met, a company must measure the tax position to determine the amount to recognize in the financial statements. The application of income tax law is inherently complex. Laws and ~~2019~~regulation in this area are voluminous and are often ambiguous. As such, we are required to make many subjective assumptions and judgments regarding the income tax exposures. Interpretations and guidance surrounding income tax laws and regulations change over time. As such, changes in the subjective assumptions and judgments can materially affect amounts recognized in the balance sheets and statements of income.

~~During~~The ~~the years ended December 31, 2020 and 2019, the~~ Company ~~borrowed~~has ~~$18,749~~no ~~and~~unrecognized ~~$34,557,~~tax ~~respectively~~benefit, ~~from~~which ~~our~~would ~~current~~affect ~~President and director, Vincent C. Lombardi, in order to cover expenses being incurred in connection with~~ the ~~Company’s~~effective ~~commercial~~tax ~~hemp~~rate ~~farming~~if ~~activities and general and administrative expenses as detailed below~~recognized. A ~~repayment~~There ofhas ~~$30,000~~been onno ~~these~~significant ~~related~~change ~~party notes was made~~ in ~~2020~~the ~~and~~unrecognized ~~none~~tax benefit during the year ended December 31, ~~2019~~2021.

~~The~~We ~~Company~~classify ~~has~~interest ~~incurred~~and anpenalties ~~interest~~arising ~~expense~~from ofthe ~~$4,645~~underpayment ~~and~~of ~~$569~~income ~~during~~taxes in the ~~years~~statement ~~ended~~of ~~December~~income ~~31,~~under ~~2020~~general and ~~2019,~~administrative ~~respectively~~expenses. ~~The~~ ~~Company~~As ~~has~~of ~~interest~~December ~~accrued~~31, on2021, ~~the~~we ~~above~~had ~~notes~~no inaccrued ~~the~~interest ~~amount~~or ofpenalties ~~$5,214~~related ~~and~~to ~~$569~~uncertain attax ~~December 31, 2020 and 2019~~positions.

NOTE 7 – Income Taxes

The Company adopted the provisions of ASC 740-10. ASC 740-10 clarifies the accounting for uncertainty in income taxes recognized in a company’s financial statements. ASC 740-10 requires a company to determine whether it is more likely than not that a tax position will be sustained upon examination based upon the technical merits of the position. If the more-likely-than-not threshold is met, a company must measure the tax position to determine the amount to recognize in the financial statements. The application of income tax law is inherently complex. Laws and regulation in this area are voluminous and are often ambiguous. As such, we are required to make many subjective assumptions and judgments regarding the income tax exposures. Interpretations and guidance surrounding income tax laws and regulations change over time. As such, changes in the subjective assumptions and judgments can materially affect amounts recognized in the balance sheets and statements of income.

The Company has no unrecognized tax benefit, which would affect the effective tax rate if recognized. There has been no significant change in the unrecognized tax benefit during the year ended December 31, 2020.

We classify interest and penalties arising from the underpayment of income taxes in the statement of income under general and administrative expenses. As of December 31, 2020, we had no accrued interest or penalties related to uncertain tax positions.

Deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment.

3135

HIGH SIERRA TECHNOLOGIES, INC. Notes to Consolidated Financial Statements December 31, 2021 and 2020

~~Notes~~ toThe ~~Consolidated~~components ~~Financial~~of ~~Statements~~deferred income tax assets (liabilities) at December 31, 2021 and 2020, were as follows:

As of December 31, ~~2020 and 2019~~ 2021:

The components of deferred income tax assets (liabilities) at December 31, 2020 and 2019, were as follows:

	Balance	Rate	Tax
Federal loss carryforward	$1,066,214	21%	$	223,905
Valuation allowance				(223,905)
Deferred tax asset			$	-

As of December 31, 2020:

	Balance	Rate	Tax
Federal loss carryforward	$749,777	21%	$	157,453
Valuation allowance				(157,453)
Deferred tax asset			$	-

As The income tax provision differs from the amount on income tax determined by applying the U.S. federal income tax rate of 21% to pretax income from continuing operations for the years ended December 31, ~~2019~~2021 and 2020 due to the following:

	Balance	Rate	Tax
		2021		2020
Federal loss carryforward	$518,957	21%	$ 108,941
Income tax (benefit) expense		$	(66,452)	$	(64,157)
Valuation allowance			(108,941)
Non-deductible expenses			-		15,645
Deferred tax asset			$ -
Increase in valuation allowance			66,452		48,512
Provision for income taxes		$	-	$	-

~~Due~~ toNOTE ~~the~~7 ~~passage~~– ofCapital the “Tax Cuts and Jobs Act” on December 20, 2017 the rate of the U.S. Federal Income Tax dropped from 34% to 21%, which is a flat percentage tax rate used for the calculation of the deferred income tax assets.Changes

The new law also changes the rules on NOL carry forward. The 20-year limitation was eliminated, giving the taxpayer the ability to carry forward losses indefinitely. However, utilization of NOL carry forwards arising after January 1, 2018, will now be limited to 80 percent of taxable income.

The income tax provision differs from the amount on income tax determined by applying the U.S. federal income tax rate of 21% to pretax income from continuing operations for the years ended December 31, 2020 and 2019 due to the following:

		2020		2019
Income tax (benefit) expense	$	(64,157)	$	(100,012)
Non-deductible expenses		15,645		-
Increase in valuation allowance		48,512		100,012
Provision for income taxes	$	-	$	-

NOTE 8 – Capital Changes

Offering of Securities

Common stock

We are offering a maximum of 2,000,000 Shares of common stock (“Shares”) exclusively to “accredited investors”. There is no minimum number of Shares to be sold pursuant to this offering other than the minimum purchase requirement. The offering price is $1.50 per Share ($3,000,000). This offering became effective February 4, 2020 and was amended February 1, 2021 to extend the date of the offering through May 1, 2022.

The Company ~~has~~ sold ~~and issued~~ 106,667 shares of ~~its~~ common stock, ~~under~~per ~~this~~the offering todescribed ~~independent~~above ~~investors~~in this note, at $1.50 per share for gross proceeds of $160,001 during the year ended December 31, 2020.

32The Company has sold 100,002 shares of its common stock for gross proceeds of $150,000 under this offering during the year ended December 31, 2021.

~~HIGH~~During ~~SIERRA~~the ~~TECHNOLOGIES~~year ended December 31, ~~INC~~2021, the Company issued 55,000 shares of its common stock for services valued at $82,500.

~~Notes to Consolidated Financial Statements~~36

HIGH SIERRA TECHNOLOGIES, INC. Notes to Consolidated Financial Statements December 31, ~~2020~~2021 and ~~2019~~ 2020

Secured Convertible Notes

Additionally, we are offering up to $1,000,000 in Series 2 Senior Convertible Secured Promissory Notes exclusively to “accredited investors”. The Notes will be in a minimum face amount/increment of $10,000 for a term of three years and shall bear interest at a rate at eight Percent (8%) per annum. The Notes will automatically convert to Common Stock of the Company if the Company has received $1,000,000 from its offering or any other source or sources at a conversion price of $1.50 per share. The Notes can also be voluntarily converted by the holder. The Payee shall also be issued Warrants for the purchase of common stock in the Company with a value equal to fifty percent (50%) of the face amount of the Note and effective as of the date of any Conversion to shares of common stock in the Company. Such Warrants shall be priced at $1.50 per share during the three-year term of the Note or any extension of the Note.

The Company ~~has~~ sold $50,000 of the Series 2 Senior Convertible Secured Promissory Notes in the year ended December 31, 2020, and the Company sold $50,000 of these Notes during the year ended December 31, 2021.

These securities have not been registered with the United States Securities and Exchange Commission or with any state securities agency. These securities are being offered pursuant to exemptions from the registration requirements of the Securities Act of 1933, as amended pursuant to Rule 506 of Regulation D, and from the registration requirements of the securities laws of the states in which the securities will be offered. The securities are subject to certain restrictions on resale and may be resold only as permitted under applicable federal and state securities laws.

Warrants

Under an Investment Banking Agreement, the Company issued 50,000 warrants. The exercise price per share of the Common Stock under this Warrant is $.01 and is fully vested on the Issue Date and is non-cancellable nor non-redeemable.

Common Stock Purchase Warrants

As of December 31, ~~2020 and 2019~~2021, the following common stock purchase warrants were outstanding:

	Warrants		Weighted Average Exercise Price		~~Weighted Average Exercise Price~~
Outstanding – December 31, 2018		-			$	-
Outstanding – December 31, 2020	50,000		$	.01
Granted	-	-		-		-
Canceled/forfeited	-	-		-		-
Exercised	(10,000	-)		.01		-
Outstanding – December 31, 2019		-				-
Outstanding – December 31, 2021	40,000		$	.01
Granted		50,000	(1)			.01
Canceled/forfeited		-				-
Exercised		-				-
Outstanding – December 31, 2020		50,000			$	.01

(1) The Company granted 50,000 common stock purchase warrants in December 2020 to exercise at a purchase price of $.01. During ~~2020~~the year ended December 31, ~~none~~2021, 10,000 of ~~the~~these purchase warrants were exercised for proceeds of $100.

3337

HIGH SIERRA TECHNOLOGIES, INC. Notes to Consolidated Financial Statements December 31, 2021 and 2020

Notes to Consolidated Financial Statements

December 31, 2020 and 2019

The fair value of the outstanding common stock purchase warrants was calculated using the Black-Scholes option-pricing model with the following assumptions at the measurement date(s):

		Measurement date
Dividend yield		0%
Expected volatility		97.90~172.75%
Risk-free interest rate		0.16~1.72%
Expected life (years)		2.71~5.00
Stock Price		$1.50
Exercise Price		$0.01

The Company recorded $74,500 to general and administrative expense for the value of the warrants granted in 2020.

NOTE 98 – Contingencies, Commitments, Legal Matters and Consulting Agreements

Management of the Company has conducted a diligent search and concluded that there were no commitments, contingencies, or legal matters pending at the balance sheet dates, other than what has been disclosed below. The Company has ~~entered~~cancelled ~~into~~one ~~several~~ Consulting Agreements for the marketing of its securities. Additionally, ~~all~~the ofCompany ~~which~~has ~~will~~terminated ~~terminate~~its inInvestment ~~the~~Banking ~~year~~Agreement on November 10, 2021.

OnThe ~~May 13, 2019, the~~ Company has entered into an ~~Agricultural~~agreement ~~Lease~~to ~~for~~lease ~~approximately~~a ~~200~~small ~~acres~~commercial space in ~~Northern~~Reno ~~Nevada~~ to ~~plant~~be ~~its~~used ~~Hemp~~as ~~Grow~~a ~~for~~Research ~~2019~~and Development Facility. ~~The~~ ~~Company~~It is no1,475 ~~longer~~square ~~operating~~feet ~~under~~and ~~this~~the ~~Agricultural~~monthly ~~Lease~~rent is $1,254 plus $203 in estimated CAM charges. ~~Thus~~The ~~there~~lease ~~are~~will nobe ~~contingent~~for ~~liabilities~~one ~~thereunder~~year and has options for two additional years.

The ~~term~~Lease ofAgreement ~~the~~was ~~lease~~amended ison ~~for~~January ~~five~~30, ~~years~~2022 ~~commencing~~to ~~May~~take ~~18,~~effect ~~2019~~on ~~through~~February ~~May 17~~1, ~~2024~~2022.

~~There~~On ~~are~~December no28, ~~minimum fixed monthly payments due on this lease~~2021, ~~but~~the anCompany ~~annual~~executed ~~participation~~a ~~bonus~~non-binding inLetter anof ~~amount~~Intent ~~equal~~ to ~~fifteen~~acquire ~~percent~~an ofOregon ~~the~~Corporation ~~gross~~specializing ~~crop~~in ~~yield~~hemp-related ~~from~~products ~~the~~in ~~leasehold~~a ~~properties. The~~Share ~~Gross~~Exchange ~~Crop~~Transaction ~~Yield~~pursuant isto ~~defined~~26 byU.S.C. ~~the~~§368. ~~actual~~This ~~amount~~Letter ~~received~~of ~~from~~Intent ~~the~~was ~~crop~~subsequently ~~harvest~~amended ~~less~~on ~~all~~January ~~expenses derived from the growing~~22, ~~processing and sale of the crop harvested from the Property~~2022.

~~The~~ ~~Company~~NOTE is9 ~~solely~~– ~~responsible~~Subsequent ~~for~~Events all crop care, labor, irrigation, insurance, taxes, repairs and maintenance of the crop, equipment and other costs of planting, raising and harvesting of crops. The Company is responsible for all other miscellaneous cost to grow and take it to market. As the Company is no longer engaged in the activities contemplated by the Agricultural Lease, the Company is no longer subject to any such liabilities.

~~Due~~In toaccordance ~~the~~with ~~lease~~ASC ~~payments being variable~~855, the Company has ~~not~~analyzed ~~recorded~~its aoperations ~~right~~subsequent ofto ~~use~~December ~~asset~~31, or2021 ~~lease~~through ~~liability on~~ the ~~balance~~date ~~sheet~~these ~~and~~financial ~~will~~statements ~~recognize~~were ~~the~~issued ~~variable~~and ~~lease~~has ~~payments~~determined inthat ~~the~~it ~~period~~has ~~when~~ the ~~obligation~~following ~~for~~material ~~those~~subsequent ~~payments~~events ~~has~~to ~~occurred~~disclose in ~~accordance~~these ~~with~~financial ~~ASC 842, Leases~~statements.

~~No gross crop yields have been achieved by the Company to date, and therefore no lease payments have been made or required under the lease terms.~~ The ~~Hemp~~Lease ~~Grow~~Agreement ~~farming~~for ~~activities were ceased at~~ the ~~end~~new ofResearch ~~2019~~ and ~~the~~Development ~~leased~~Facility ~~property~~was isamended ~~not~~as ~~currently~~further ~~being~~described ~~used~~in byNote ~~the~~8, ~~Company~~above.

34On February 10, 2022, the Company sold 33,334 shares of its common stock for a total consideration of $50,000 pursuant to its Private Placement Memorandum dated February 1, 2021.

~~HIGH~~On ~~SIERRA~~February ~~TECHNOLOGIES~~16, ~~INC~~2022, the Company sold of $100,000 of Notes pursuant to its Secured Note Private Placement Memorandum dated October 1, 2020.

~~Notes~~On February 18, 2022, the Company executed a non-binding Letter of Intent to ~~Consolidated~~form ~~Financial~~a ~~Statements~~Joint Venture to produce, market and distribute hemp cigarettes and hemp-based products in the United States, Canada and Mexico using its Patented and Patent Pending Technologies which will be licensed to a new joint venture entity to be formed. The Company is in the process of negotiating definitive agreements related to this Letter of Intent.

~~December 31, 2020 and 2019~~ 38

NOTE 10 – Subsequent Events

In accordance with ASC 855-10, the Company has analyzed its operations subsequent to December 31, 2020 through the date these financial statements were issued and has determined that it does not have any material subsequent events to disclose in these financial statements other than the events described immediately below.

In 2021, the Company issued 20,000 shares total of its common stock to two unrelated parties. 10,000 of the shares were issued for $2,000 of services rendered, and the other 10,000 shares were issued pursuant to the exercise of a warrant at an exercise price of $0.01 per share. Also in 2021, the Company issued 10,000 shares of its common stock to its Vice President, Jeffrey M. Pogol, for $2,000 of services rendered.

ITEM 9: CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None; Not applicable.

ITEM 9A: CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

We maintain disclosure controls and procedures, as defined in Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934 (the “Exchange Act”), that are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Principal Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer of the effectiveness of the design and operation of our disclosure controls and procedures as of December 31, ~~2020~~2021. Based on the evaluation of these disclosure controls and procedures, and in light of the material weaknesses found in our internal controls over financial reporting, our Chief Executive Officer concluded that our disclosure controls and procedures were not effective. Management anticipates that such disclosure controls and procedures will not be effective until the material weaknesses are remediated.

Management’s Annual Report on Internal Control Over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act). Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with accounting principles generally accepted in the United States.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Therefore, even those systems determined to be effective can provide only reasonable assurance of achieving their control objectives.

Our management evaluated the effectiveness of our internal controls over financial reporting as of December 31, ~~2020~~2021. In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO” - 2013) in Internal Control – Integrated Framework. Based on this evaluation, our management, with the participation of the Chief Executive Officer and our Chief Financial Officer, concluded that, as of December 31, ~~2020~~2021, our internal controls over financial reporting were not effective.

Our internal controls are not effective for the following reasons: (i) there is an inadequate segregation of duties consistent with control objectives, (ii) the Company does not have an audit committee with a financial expert, and thus the Company lacks the board oversight role within the financial reporting process.

In order to mitigate the foregoing material weakness, we have engaged an outside accounting consultant with significant experience in the preparation of financial statements in conformity with GAAP to assist us in the preparation of our financial statements to ensure that these financial statements are prepared in conformity with GAAP. We will continue to monitor the effectiveness of this action and make any changes that our management deems appropriate.

We would need to hire additional staff to provide greater segregation of duties. Currently, it is not feasible to hire additional staff to obtain optimal segregation of duties. Management will continue to reassess this matter to ~~determine whether improvement in segregation of duty is feasible. In addition, we would need to expand our board to include independent members.~~

3639

determine whether improvement in segregation of duty is feasible. In addition, we would need to expand our board to include independent members.

This Annual Report does not include an attestation report of our registered public accounting firm regarding our internal controls over financial reporting. Management’s report was not subject to attestation by our registered public accounting firm pursuant to rules of the SEC that permit us to provide only management’s report in this Annual Report.

Changes in Internal Control Over Financial Reporting

There have been no changes in internal control over financial reporting.

ITEM 9B: OTHER INFORMATION

None; not applicable.

ITEM 9C: DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

None; not applicable.

PART III

ITEM 10: DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE

Identification of Directors and Executive Officers

Below are the names of and certain information regarding the Company’s current executive officers and directors. All of these persons were appointed effective as of the closing of the acquisition of High Sierra:

			Date Named to Board of Directors/as Executive Officer
				Date Named to Board of
Name	Age	Position		Directors/as Executive Officer
Vincent C. Lombardi	5657	Director, Chief Executive Officer and President		December 2018
Gregg W. Koechlein	7273	Chief Financial Officer, Chief Operating Officer, Treasurer, Secretary and Director		December 2018 as an officer and March 2019 as a Director
Glenn C. Miller	7071	Chief Scientific Officer		December 2018
Jeffrey M. Pogol	6263	Vice President		December 2019

Directors are elected to serve until the next annual meeting of stockholders and until their successors are elected and qualified. Directors are elected by a plurality of the votes cast at the annual meeting of stockholders and hold office until the expiration of the term for which he or she was elected and until a successor has been elected and qualified.

A majority of the authorized number of directors constitutes a quorum of the Board of Directors for the transaction of business. The directors must be present at the meeting to constitute a quorum. However, any action required or permitted to be taken by the Board of Directors may be taken without a meeting if all members of the Board of Directors individually or collectively consent in writing to the action.

The authorized number of directors to constitute our Board of Directors is presently two. Pursuant to the terms of the Share Exchange Agreement, High Sierra and the Company agreed that the Company’s Board of Directors, as of the Closing of the Share Exchange, would consist of two members. Our Board of Directors is now comprised of Messrs. Lombardi and Koechlein. Executive officers are appointed by the Board of Directors and serve at its pleasure.

The principal occupation and business experience during the past five years for our executive officers and directors is as follows:

Vincent C. Lombardi, Ph.D., President, Chief Executive Officer and Director

Dr. Lombardi has served as the Company’s Chief Executive Officer, President and as a Director since December 31, 2018. He has served in those capacities for High Sierra since its inception in August 2018 and continues to do so. For the past five years, Dr. Lombardi has managed a basic and clinical research program. He received his Ph.D. in Biochemistry from the University of Nevada, Reno in 2006. He has previously served as the Director of Research for the Nevada Center for Biomedical Research and is also an Adjunct Assistant Professor of Biochemistry with the University of Nevada, College of Agriculture, Biotech, Natural Resources. While Dr. Lombardi is a classically trained Biochemist, he has extensive research experience in the field of Immunology and specifically, in studying the innate immune system and how it relates to chronic disease. He also has substantial experience in clinical research, has authored dozens of peer-reviewed scientific publications. Prior to his career in science, Dr. Lombardi worked in the investment industry from 1983 to 1999 as a securities broker, an over-the-counter securities trader and as an investment banker. Dr. Lombardi is the inventor of High Sierra’s intellectual property and will guide the Company as its President and Chief Executive Officer.

For the past five years, Dr. Lombardi has managed a basic and clinical research program. He received his Ph.D. in Biochemistry from the University of Nevada, Reno in 2006. He has previously served as the Director of Research for the Nevada Center for Biomedical Research and is also an Adjunct Assistant Professor of Biochemistry with the University of Nevada, College of Agriculture, Biotech, Natural Resources. While Dr. Lombardi is a classically trained Biochemist, he has extensive research experience in the field of Immunology and specifically, in studying the innate immune system and how it relates to chronic disease. He also has substantial experience in clinical research, has authored dozens of peer-reviewed scientific publications. Prior to his career in science, Dr. Lombardi worked in the investment industry from 1983 to 1999 as a securities broker, an over-the-counter securities trader and as an investment banker. Dr. Lombardi is the inventor of High Sierra’s intellectual property and will guide the Company as its President and Chief Executive Officer.

Gregg W. Koechlein, Esq., Chief Operating Officer, Chief Financial Officer, Secretary, Treasurer, General Counsel and Director

Mr. Koechlein has served as the Company’s Chief Operating Officer, Chief Financial Officer, Secretary, Treasurer and General Counsel since December 31, 2018. He has served as a Director since March 2019. He has served in those capacities for High Sierra since its inception in August 2018 and continues to do so. Mr. Koechlein has maintained an active law practice for the last five years focusing mainly on transactional work, state and federal court litigation and federal appellate work. He has also provided consulting services to various clients in the medical, clinical laboratory and restaurant sectors. Mr. Koechlein received his Juris Doctor degree from the Loyola Law School in Los Angeles, California in 1984. He brings to the Company over 33 years of legal experience and over 45 years of business experience. From 1987 to 1989 Mr. Koechlein was Vice President of Manufacturing and General Counsel of Super Shops, Inc. He served as its President, Chief Operating Officer and General Counsel from 1989 to 1997. As President, he was responsible for all operational and strategic aspects of a chain of 165 retail stores in 31 states, employing nearly 2000 people. These operations included a mail order sister company startup that had first year annual revenues of $35 million. During his tenure, Super Shops, Inc. grew from 53 to 165 stores, one to four warehouses and the annual consolidated revenues grew from $80 million to approximately $250 million. During this same time period, the Mallory, Inc. subsidiary nearly tripled its annual revenues.

Jeffrey M. Pogol, Vice President

Mr. Pogol was elected as a Vice President of the Company in December 2019. Mr. Pogol has over 30 years of experience in the field of sales and marketing. In 1985 he served as a sales closer at the Tahoe Sands Resort in Tahoe Vista, California. From 1988 to 1992 Mr. Pogol was the head of High Technology Sales for Migent Software Company located in Incline Village, Nevada. From 1992 to 1995 Mr. Pogol served as a High Technology Sales Representative for the Market Broadcasting Corporation. From 1995 to 1998 Mr. Pogol was an owner/partner in a clothing retailer known as Name Brand Liquidators in Truckee, California. Since that time, Mr. Pogol has worked in the Mortgage Banking Industry. During this period, Mr. Pogol has earned numerous awards and honors for excellence in sales and team leadership.

Glenn C. Miller, Ph.D., Chief Scientific Officer

Dr. Miller serves as the Company’s Chief Scientific Officer. He has served in those capacities for High Sierra since its inception in August 2018 and continues to do so. For the past five years, Dr. Miller has managed a basic research program. Dr. Miller is a Professor of Natural Resources and Environmental Science at the University of Nevada, Reno. He received his B.S. in Chemistry from the University of California, Santa Barbara and a Ph.D. in Agricultural and Environmental Chemistry (1977) from the University of California at Davis. Following graduate studies, he spent a year of postdoctoral study at the EPA’s Environmental Research Laboratory in Athens, Georgia. He has been on the UNR faculty since 1978 and was Director of the Graduate Program in Environmental Sciences and Health from 1996-2006 and Director of the Center for Environmental Sciences and Engineering from 1999-2003. Dr. Miller also currently serves on the State of Nevada’s Medical Marijuana Independent Laboratory Advisory Committee. As a member of the Scientific Advisory Committee, Dr. Miller brings over 40 years of scientific experience to the Company.

3841

and Health from 1996-2006 and Director of the Center for Environmental Sciences and Engineering from 1999-2003. Dr. Miller also currently serves on the State of Nevada’s Medical Marijuana Independent Laboratory Advisory Committee. As a member of the Scientific Advisory Committee, Dr. Miller brings over 40 years of scientific experience to the Company.

Scientific Advisory Committee

The Company’s Scientific Advisory Committee consists of Karen Schlauch, Ph.D., Timothy Bailey, Ph.D. and Ruben Dagda, Ph.D. Its purpose is to advise the Board of Directors concerning scientific matters related to the development and application of existing and new technologies. Persons may be elected to, and removed from, the committee by vote of the Company’s Board of Directors. Certain information concerning the persons who serve on the committee follows:

Karen Schlauch, Ph.D.

Dr. Schlauch received a B.S. Mathematics / Computer Science from the University of Illinois in 1989. She received a M.A. in Mathematics in 1991 from Eastern Illinois University as well as a M.S. in Mathematics from New Mexico State University in 1994. Dr. Schlauch received her Ph.D. in Mathematics from New Mexico State University in 1998. She completed her Post-Doctoral Fellowship in 2000 at the National Center for Genome Resources in Santa Fe, New Mexico. Her interest in the fields of human biostatistics and bioinformatics began with research at the human genetics research institute at DeCODE Genetics in Reykyavik, Iceland, and continued with genomics research in obesity and liver disease at George Mason University and INOVA Fairfax Hospital, as well as at the genotyping facility at the Boston University School of Medicine. Her current work is centered on providing developing new and robust mathematical and (bio) statistical tools to analyze large whole-genome datasets for researchers state-wide, including GWAS studies, next-generation experiments, and Mass Spectrometry studies.

Timothy Bailey, Ph.D.

Dr. Bailey received a B.S. in Mathematical Science in 1977 from Stanford University. He received both a M.S. in 1991 and a Ph.D. in Computer Science from the University of California, San Diego. He completed a Post-Doctoral Fellowship at the San Diego Supercomputer Center in 2000 and a second Post-Doctoral Fellowship at the Karolinska Institute in Stockholm, Sweden in 2001. From 2002 to 2015, Dr. Bailey was a Professor and held various Research Fellowships at the University of Queensland, Brisbane, Old, Australia. Dr. Bailey was the creator of the sequence motif discovery algorithm “MEME”. This is one of the most heavily used software tools in bioinformatics and has been used to discover and characterize patterns in DNA, RNA and protein sequences. These patterns encode biological signals such as transcription binding sites, splice junctions and the active sites of enzymes. The discovery and characterization of motifs has been important in the study of many biological processes including the regulation of gene expression. MEME has been used and cited over 7000 times. MEME was one of the first algorithms introduced to attack the problem of motif discovery in unaligned sets of sequences, and continues to be used by thousands of biologists each year. In addition to motif discovery tools, Dr. Bailey’s research has also developed several widely-used tools used for scanning DNA, RNA or protein sequences for motifs represented as weight matrices. These tools can look for sequences enriched in a set of motifs (MAST), individual motif occurrences (FIMO and GLAM2Scan), and sequences containing clusters of motifs characteristic of gene regulatory modules (MCAST).

Ruben Dagda, Ph.D.

Dr. Dagda received his Ph.D. in pharmacology from the University of Iowa and his postdoctoral training in neuropathology at the University of Pittsburgh School of Medicine. He is currently investigating the molecular mechanisms that lead to mitochondrial dysfunction and oxidative stress in cell culture, tissue and animal models of Parkinson’s disease. He has authored over 42 research manuscripts and review articles in the areas of toxicology, mitochondrial function, autophagy, neurodegeneration, neuropathology and neurobiology. As an Associate Professor at the University of Nevada, Reno School of Medicine, he is currently investigating the pathological mechanisms by which neurons degenerate in models of Parkinson’s disease and Alzheimer’s disease. He currently holds a provisional patent to develop intranasal formulations that can restore brain energy, and reverse neurodegeneration and motor symptoms as shown by in vivo animal models of Parkinson’s disease. In addition, he is the director of the Cell Imaging and Metabolic Core that is equipped with state-of-the art automated fluorescent imager and several metabolic analyzers to screen for compounds that can reverse neurodegeneration and mitochondrial dysfunction at the University of Nevada, Reno School of Medicine.

3942

is the director of the Cell Imaging and Metabolic Core that is equipped with state-of-the art automated fluorescent imager and several metabolic analyzers to screen for compounds that can reverse neurodegeneration and mitochondrial dysfunction at the University of Nevada, Reno School of Medicine.

Directorships Held in Other Reporting Companies

None of our directors or executive officers is a director of aanother company that is required to file reports under Sections 15 or 13(d) of the Exchange Act.

Director Independence

We have no independent directors at the present time. We are not currently subject to listing requirements of any national securities exchange or inter-dealer quotation system which has requirements that a majority of the board of directors be “independent” and, as a result, we are not at this time required to have our Board of Directors comprised of a majority of “independent directors.”

Family Relationships

There are no family relationships among our Directors or executive officers.

Involvement in Certain Legal Proceedings

During the past 10 years, no director, promoter or control person of the Company:

· has filed a petition under federal bankruptcy laws or any state insolvency laws, nor had a receiver, fiscal agent or similar officer appointed by a court for the business or property of such person, or any partnership in which he was a general partner at or within two years before the time of such filing, or any corporation or business association of which he was an executive officer at or within two years before the time of such filing;

~~has~~· ~~filed~~was aconvicted ~~petition~~in ~~under federal bankruptcy laws or any state insolvency laws, nor had~~ a ~~receiver,~~criminal ~~fiscal~~proceeding ~~agent~~ or ~~similar~~named ~~officer~~subject ~~appointed~~to by a ~~court~~pending ~~for~~criminal ~~the~~proceeding ~~business~~(excluding ortraffic ~~property~~violations ofand ~~such~~other ~~person,~~minor or any partnership in which he was a general partner at or within two years before the time of such filing, or any corporation or business association of which he was an executive officer at or within two years before the time of such filingoffenses);

· was the subject of any order, judgment or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining him or her from or otherwise limiting the following activities:

was convicted in a criminal proceeding or named subject to a pending criminal proceeding (excluding traffic violations and other minor offenses);

was the subject of any order, judgment or decree, not subsequently reversed, suspended or vacated, of any court of competent jurisdiction, permanently or temporarily enjoining him or her from or otherwise limiting the following activities:

Acting as a futures commission merchant, introducing broker, commodity trading advisor, commodity pool operator, floor broker, leverage transaction merchant, any other person regulated by the Commodity Futures Trading Commission, or an associated person of any of the foregoing, or as an investment adviser, underwriter, broker or dealer in securities, or as an affiliated person, director or employee of any investment company, bank, savings and loan association or insurance company, or engaging in or continuing any conduct or practice in connection with such activity;

Engaging in any type of business practice; or

Engaging in any activity in connection with the purchase or sale of any security or commodity or in connection with any violation of Federal or State securities laws or Federal commodities laws;

· was the subject of any order, judgment or decree, not subsequently reversed, suspended or vacated, of any Federal or State authority barring, suspending or otherwise limiting for more than 60 days the right of such person to engage in any activity described in the preceding bullet point, or to be associated with persons engaged in any such activity;

· was ~~the~~found ~~subject~~by a court of ~~any~~competent ~~order,~~jurisdiction ~~judgment~~in ora ~~decree,~~civil ~~not~~action ~~subsequently~~or ~~reversed,~~by ~~suspended~~the orSEC ~~vacated,~~to ofhave violated any Federal or State ~~authority~~securities ~~barring~~law, ~~suspending~~and ~~or otherwise limiting for more than 60 days~~ the ~~right~~judgment ofin such ~~person~~civil toaction ~~engage~~or infinding ~~any~~by ~~activity~~the ~~described~~SEC inhas ~~the~~not ~~preceding~~been ~~bullet~~subsequently ~~point~~reversed, suspended, or ~~to be associated with persons engaged in any such activity~~vacated;

·43

· was found by a court of competent jurisdiction in a civil action or by the ~~SEC~~Commodity Futures Trading Commission to have violated any Federal orcommodities ~~State securities~~ law, and the judgment in such civil action or finding by the ~~SEC~~Commodity Futures Trading Commission has not been subsequently reversed, suspended, or vacated;

· was the subject of, or a party to, any Federal or State judicial or administrative order, judgment, decree, or finding, not subsequently reversed, suspended or vacated, relating to an alleged violation of:

was found by a court of competent jurisdiction in a civil action or by the Commodity Futures Trading Commission to have violated any Federal commodities law, and the judgment in such civil action or finding

by the Commodity Futures Trading Commission has not been subsequently reversed, suspended or vacated;

was the subject of, or a party to, any Federal or State judicial or administrative order, judgment, decree, or finding, not subsequently reversed, suspended or vacated, relating to an alleged violation of:

any Federal or State securities or commodities law or regulation; or

any law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order; or

any law or regulation prohibiting mail or wire fraud in connection with any business activity; or

· was the subject of, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, or any self-regulatory organization (as defined in Section 3(a)(26) of the Exchange Act), any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act, or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member.

was the subject of, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, or any self-regulatory organization (as defined in Section 3(a)(26) of the Exchange Act), any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act, or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member.

Promoters and control persons.

See the heading “Transactions with Related Persons” in Part III, Item 13, below.

Compliance with Section 16(a) of the Exchange Act

Our shares of common stock are registered under the Exchange Act, and therefore our officers, directors and holders of more than 10% of our outstanding shares are subject to the provisions of Section 16(a) which requires them to file with the SEC initial reports of ownership and reports of changes in ownership of common stock and our other equity securities. Officers, directors and greater than 10% beneficial owners are required by SEC regulations to furnish us with copies of all Section 16(a) reports they file. Based solely upon our review during the fiscal year ended December 31, ~~2020~~2021, Mr. Pogol ~~did~~filed ~~not file~~ an initial Form 3 Report ~~when~~late heon ~~became~~April an29, ~~officer of the Company~~2021, ~~nor~~and ~~did~~ he ~~file~~filed a Form 4 report ~~when~~late on April 29, 2021 after he acquired 10,000 shares of the Company’s common stock on February 26, 2021. ~~He is in the process of completing and filing those reports now.~~

Code of Ethics

We have adopted a Code of Ethics for our principal executive and financial officers. Our Code of Ethics was filed as an Exhibit to Amendment No. 2 to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on August 7, 2019.

Corporate Governance

Nominating Committee

We have not established a Nominating Committee because of our limited operations; and because we have only two directors and executive officers, we believe that we are able to effectively manage the issues normally considered by a Nominating Committee. Following the entry into any business combination or the completion of any acquisition, merger or reorganization, a further review of this issue will no doubt be necessitated and undertaken by new management.

Audit Committee

We have not established an Audit Committee because of our limited operations; and because we have only two directors and executive officers, we believe that we are able to effectively manage the issues normally considered by an Audit Committee. Following the entry into any business combination or the completion of any acquisition, ~~merger or reorganization, a further review of this issue will no doubt be necessitated and undertaken by new management.~~

4144

merger or reorganization, a further review of this issue will no doubt be necessitated and undertaken by new management.

ITEM 11: EXECUTIVE COMPENSATION

The following tables disclose certain compensation information concerning the Company’s officers and directors during the past two fiscal years. ~~Please note that Michael Vardakis resigned as an officer on December 31, 2018 and as a director on March 25, 2019, and Jeffrey M. Pogol became a Vice President in December 2019.~~

SUMMARY COMPENSATION TABLE

Name and Principal Position (a)	Year (b)	Salary ($) (c)	Bonus ($) (d)	Stock Awards ($) (e)	Option Awards ($) (f)	Non-Equity Incentive Plan Compensation ($) (g)	Nonqualified Deferred Compensation ($) (h)	All Other Compensation ($) (i)	Total Earnings ($) (j)
Vincent C. Lombardi CEO, President & Director	12/31/~~2020~~2021 12/31/~~2019~~2020	0 0	0 0	0 0	0 0	0 0	0 0	0 0	0 0
Gregg W. Koechlein CFO, COO, Sec./Treas. & Director	12/31/~~2020~~2021 12/31/~~2019~~2020	0 0	0$12,500 0	0 0	0 0	0 0	0 0	0 0	0$12,500 0
Jeffrey M. Pogol, Vice President	12/31/~~2020~~2021 12/31/~~2019~~2020	0 0	0 0	0Note 1 0	0 0	0 0	0 0	0 0	0$2,000 0
Michael Vardakis Former President & Director	12/31/2019	0	0	0	0	0	0	0	0

42Note 1: On February 26, 2021, we issued 10,000 shares of our restricted common stock to Jeffrey M. Pogol for services rendered valued in the amount of $2,000.

Outstanding Equity Awards at Fiscal Year-End

Option Awards			Stock Awards
Name	Number of Securities Underlying Unexercised Options (#) Exercisable	Number of Securities underlying Unexercised Options (#) Unexercisable	Equity Incentive Plan Awards Number of Securities Underlying Unexercised Unearned Options (#)	Option Exercise Price ($)	Option Expiration Date	Number of Shares or Units of Stock That Have Not Vested (#)	Market Value of Shares or Units of Stock That Have Not Vested ($)	Equity Incentive Plan Awards: Number of Unearned Shares, Vested Units or Other Rights That Have Not Vested (#)	Equity Incentive Plan Awards: Market or Payout Value of Unearned Shares, Units or Other Rights That Have Not Vested ($)
(a)	(b)	(c)	(d)	(e)	(f)	(g)	(h)	(i)	(j)
Vincent C. Lombardi	None	None	None	None	None	None	None	None	None
Gregg W. Koechlein	None	None	None	None	None	None	None	None	None
Jeffrey M. Pogols	None	None	None	None	None	None	None	None	None

Compensation of Directors

Name	Fees Earned or Paid in Cash ($)	Stock Awards ($)	Option Awards ($)	Non-Equity Incentive Plan Compensation ($)	Nonqualified Deferred Compensation Earnings ($)	All Other Compensation ($)	Total ($)
(a)	(b)	(c)	(d)	(e)	(f)	(g)	(h)
Vincent C. Lombardi	None	None	None	None	None	None	None
Gregg W. Koechlein	None	None	None	None	None	None	None

Mr. Koechlein was paid $7,500 for services in January 2021 and $5,000 for services in November 2021, and Mr. Pogol received 10,000 shares of the Company’s common stock in February 2021 as compensation for $2,000 of services rendered. Mr. Lombardi and Mr. Koechlein have indicated that they do not intend to draw salaries from the Company until such time as the Company has sufficient funds to support one year’s operating expenses.

ITEM 12: SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

Security Ownership of Certain Beneficial Owners

The following tables set forth the shareholdings of those persons who were principal shareholders of our common stock as of December 31, ~~2020~~2021:

4346

Ownership of Principal Shareholders

Title Of Class	Name and Address of Beneficial Owner	Amount and Nature of Beneficial Owner (1)	Percent of Class
Common	Vincent C. Lombardi 979 Westcliff Lane Reno, Nevada 89523	8,280,000	40.8047%
Common	Gregg W. Koechlein 2560 Greensboro Drive Reno, Nevada 89509	3,250,000	1615.0188%
Common	Kenny L. De Meirleir Stuivenbergbaan 89 2800 Mechelen Belgium	1,800,000	8.8780%
Common	Biored, N.V. De Tyraslaan 111 1120 Brussels Belgium	1,800,000	8.8780%
Common	Michael Vardakis 601 South State Street Salt Lake City, Utah 84111	1,~~450~~400,~~000~~720	76.1484%
Totals		16,~~580~~530,~~000~~720	8180.6979%

(1) Unless indicated otherwise, all share ownership is direct.

Unless indicated otherwise, all share ownership is direct.

SEC Rule 13d-3 generally provides that beneficial owners of securities include any person who, directly or indirectly, has or shares voting power and/or investment power with respect to such securities, and any person who has the right to acquire beneficial ownership of such security within 60 days. Any securities not outstanding which are subject to such options, warrants or conversion privileges exercisable within 60 days are treated as outstanding for the purpose of computing the percentage of outstanding securities owned by that person. Such securities are not treated as outstanding for the purpose of computing the percentage of the class owned by any other person. At the present time there are no outstanding options or warrants.

Security Ownership of Management

The following table sets forth the shareholdings of our directors and executive officers as of December 31, ~~2020~~2021:

Ownership of Officers and Directors

Title of Class	Name and Address of Beneficial Owner	Amount and Nature of Beneficial Owner	Percent of Class
Common	Vincent C. Lombardi	8,280,000	40.8047%
Common	Gregg W. Koechlein	3,250,000	1615.0188%.
Common	Jeffrey M. Pogol	010,000	0.005%
Common	Glenn C. Miller	100,000	0.5049%
Totals		11,~~630~~640,000	5756.3089%

(1) Unless indicated otherwise, all share ownership is direct.

~~Unless~~SEC ~~indicated~~Rule ~~otherwise~~13d-3 generally provides that beneficial owners of securities include any person who, ~~all~~directly ~~share~~or indirectly, has or shares voting power and/or investment power with respect to such securities, and any person who has the right to acquire beneficial ownership isof ~~direct~~such security within 60 days. Any securities not outstanding which

44are subject to such options, warrants or conversion privileges exercisable within 60 days are treated as outstanding for the purpose of computing the percentage of outstanding securities owned by that person. Such securities are not treated as outstanding for the purpose of computing the percentage of the class owned by any other person. At the present time there are no outstanding options or warrants.

for the purpose of computing the percentage of outstanding securities owned by that person. Such securities are not treated as outstanding for the purpose of computing the percentage of the class owned by any other person. At the present time there are no outstanding options or warrants.

Changes in Control

A change in control occurred December 31, 2018 when we acquired our wholly-owned subsidiary, High Sierra Technologies, Inc. To the best knowledge of management, there are no present arrangements or pledges of our securities which may result in a change in control of us.

Securities Authorized for Issuance under Equity Compensation Plans

Equity Compensation Plan Information

Plan Category	Number of Securities to be issued upon exercise of outstanding options, warrants and rights	Weighted-average exercise price of outstanding options, warrants and rights	Number of securities remaining available for future issuance under equity compensation plans excluding securities reflected in column (a)
	(a)	(b)	(c)
Equity compensation plans approved by security holders	None	None	None
Equity compensation plans not approved by security holders	None	None	None
Total	None	None	None

ITEM 13: CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTORS INDEPENDENCE

Transactions with Related Persons

During the years ended December 31, ~~2020~~2021 and ~~2019~~2020, the Company borrowed $~~18,749~~0 and $3418,~~557~~749, respectively, from our current President and director, Vincent C. Lombardi, in order to cover ~~expenses being incurred in connection with the Company’s commercial hemp farming activities and~~ general and administrative expenses ~~as detailed below~~. A repayment of $3010,000 on these related party notes was made in ~~2020~~2021 and ~~none~~$30,000 during the year ended December 31, ~~2019~~2020.

The Company has incurred an interest expense – related party of $42,~~645~~152 and $~~569~~4,645 during the years ended December 31, ~~2020~~2021 and ~~2019~~2020 on the amounts owed to our current President and director, Vincent C. Lombardi. The Company has interest accrued – related party on the above notes in the amount of $57,~~214~~366 and $~~569~~ 12,714 at December 31, ~~2020~~2021 and ~~2019~~2020.

Promoters and Certain Control Persons

See the heading “Transactions with Related Persons” above.

Parents of the Smaller Reporting Company

We have no parents.

Director Independence

We do not have any independent directors serving on our Board of Directors, and we are not required to have

4548

independent directors.

ITEM 14: PRINCIPAL ACCOUNTANTING FEES AND SERVICES

The following is a summary of the fees billed to us by our principal accountants during the fiscal years ended December 31, ~~2020~~2021, and ~~2019~~2020:

Fee Category		~~2020~~2021	~~2019~~2020
Audit Fees	$	9$12,~~750~~250	$	9,~~500~~750
Audit-related Fees	$	0	$	0
Tax Fees	$	0	$	0
All Other Fees	$	0	$	0
Total Fees	$	9$12,~~750~~250	$	9,~~500~~750

Audit Fees - Consists of fees for professional services rendered by our principal accountants for the audit of our annual financial statements and review of the financial statements included in our Forms 10-Q or services that are normally provided by our principal accountants in connection with statutory and regulatory filings or engagements.

Audit-related Fees - Consists of fees for assurance and related services by our principal accountants that are reasonably related to the performance of the audit or review of our financial statements and are not reported under “Audit fees.”

Tax Fees - Consists of fees for professional services rendered by our principal accountants for tax compliance, tax advice and tax planning.

All Other Fees - Consists of fees for products and services provided by our principal accountants, other than the services reported under “Audit fees,” “Audit-related fees,” and “Tax fees” above.

Policy on Audit Committee Pre-Approval of Audit and Permissible Non-Audit Services of Independent Auditors

We have not adopted an Audit Committee; therefore, there is no Audit Committee policy in this regard. However, we do require approval in advance of the performance of professional services to be provided to us by our principal accountant. Additionally, all services rendered by our principal accountant are performed pursuant to a written engagement letter between us and the principal accountant.

PART IV

ITEM 15: EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

(a)(1)(2) Financial Statements. See our audited consolidated financial statements for the year ended December 31, 2017, contained in Part II, Item 8, above, which are incorporated herein by this reference.

(a)(3) Exhibits. The following exhibits are filed as part of this Annual Report:

Exhibit No. Exhibit Description

3.1*	Articles of Incorporation filed May 9, 1996
3.2*	Amended and Restated Articles of Incorporation
3.3*	By-Laws
10.1*	Promissory Note with Larry Mamey dated June 6, 2019
10.2*	Promissory Note with Biored N.V., a Belgian corporation, dated July 30, 2019
10.3**	Promissory Note with Kenny L. DeMeirleir dated August 12, 2020
10.4***	Promissory Note with Michael Vardakis dated December 31, 2020
10.5***	Promissory Note with Vincent C. Lombardi dated December 31, 2020
10.6***	Promissory Note with Michael Vardakis dated December 31, 2020

~~Exhibit No. Exhibit Description~~49

3.1*	Articles of Incorporation filed May 9, 1996
10.7***	Amended Consulting Agreement with Stanley Berk/Steven Leatherman (SBSL Consultants) and Jeff Baclet/Tom Prutzman (Consultants) dated December 28, 2020
3.2*	Amended and Restated Articles of Incorporation
10.8***	Form of Series 2 Senior Convertible Secured Promissory Note
3.3*	By-Laws
10.9	Tenth Amendment to Promissory Note with Larry Mamey dated February 11, 2022 – Filed Herein
10.1*	Promissory Note with Larry Mamey dated June 6, 2019
10.10****	Third Amendment to Promissory Note with Biored, N.V. dated July 29, 2021
10.2*	Promissory Note with Biored N.V., a Belgian corporation, dated July 30, 2019
10.11****	First Amendment to Promissory Note with Kenny L. DeMeirleir dated August 6, 2021
10.3**	Promissory Note with Kenny L. DeMeirleir dated August 12, 2020
10.12	Second Amendment to Promissory Note with Michael Vardakis dated June 22, 2021 – Filed Herein
10.4	Promissory Note with Michael Vardakis dated December 31, 2020 – Filed Herein
10.13	Second Amendment to Promissory Note with Vincent C. Lombardi dated June 18, 2021 – Filed Herein
10.5	Promissory Note with Vincent C. Lombardi dated December 31, 2020 - Filed Herein
10.14	Second Amendment to Promissory Note with Michael Vardakis dated June 22, 2021 – Filed Herein
10.6	Promissory Note with Michael Vardakis dated December 31, 2020 – Filed Herein
10.15*****	Lease Agreement with 3 Squirrels, LLC dated November 9, 2021
10.7**	Letter Agreement with Artemis Holdings Group, LLC dated October 14, 2020
10.16	First Amendment to Lease Agreement with 3 Squirrels, LLC dated January 30, 2022 – Filed Herein
10.8	Amended Consulting Agreement with Stanley Berk/Steven Leatherman (SBSL Consultants) and Jeff Baclet/Tom Prutzman (Consultants) dated December 28, 2020 – Filed Herein
10.9	Form of Series 2 Senior Convertible Secured Promissory Note – Filed Herein
10.10	Sixth Amendment to Promissory Note with Larry Mamey dated March 5, 2021 – Filed Herein
14*	Code of Ethics
31.1	Certification of Chief Executive Officer pursuant to section 302 of the Sarbanes-Oxley Act of 2002
31.2	Certification of Chief Financial Officer pursuant to section 302 of the Sarbanes-Oxley Act of 2002
32	Certification of Chief Executive Officer and Chief Financial Officer pursuant to section 906 of the Sarbanes-Oxley Act of 2002
101 INS	XBRL Instance Document
101 PRE	XBRL Taxonomy Extension Presentation Linkbase Document
101 LAB	XBRL Taxonomy Extension Label Linkbase Document
101 DEF	XBRL Taxonomy Extension Definition Linkbase Document
101 CAL	XBRL Taxonomy Extension Calculation Linkbase Document
101 SCH	XBRL Taxonomy Extension Schema Document

101 INS

XBRL Instance Document

101 PRE

XBRL Taxonomy Extension Presentation Linkbase Document

101 LAB

XBRL Taxonomy Extension Label Linkbase Document

101 DEF

XBRL Taxonomy Extension Definition Linkbase Document

101 CAL

XBRL Taxonomy Extension Calculation Linkbase Document

101 SCH

XBRL Taxonomy Extension Schema Document

* Incorporated by reference from the Company’s Amendment No. 2 to its Registration Statement on Form S-1 filed with the Securities and Exchange Commission on August 7, 2019.

** Incorporated by reference from the Company’s Quarterly Report on Form 10-Q for the period ended September 30, 2020 filed with the Securities and Exchange Commission on November 20, 2020.

*** Incorporated by reference from the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 filed with the Securities and Exchange Commission on April 14, 2021.

**** Incorporated by reference from the Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2021 filed with the Securities and Exchange Commission on August 16, 2021.

***** Incorporated by reference from the Company’s Quarterly Report on Form 10-Q for the period ended September 30, 2021 filed with the Securities and Exchange Commission on November 15, 2021

ITEM 16: FORM 10-K SUMMARY.

None.

4750

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

HIGH SIERRA TECHNOLOGIES, INC.

Date:	~~April~~March 1421, ~~2021~~2022	By:	/s/ Vincent C. Lombardi
			Vincent C. Lombardi
			Chief Executive Officer, President and Director

Pursuant to the requirements of the Securities Exchange Act of 1934 this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

HIGH SIERRA TECHNOLOGIES, INC.

Date:	~~April~~March 1421, ~~2021~~2022	By:	/s/ Vincent C. Lombardi
			Vincent C. Lombardi
			Chief Executive Officer, President and Director

Date:	~~April~~March 1421, ~~2021~~2022	By:	/s/ Gregg W. Koechlein
			Gregg W. Koechlein
			Chief Operating Officer, Chief Financial Officer, Secretary, Treasurer and Director

4851

Filing Compare · High Sierra Technologies, Inc.